,URL(currentwebsite)
0,
1,https://www.ema.europa.eu/en/documents/product-information/myozyme-epar-product-information_en.pdf
2,https://www.ema.europa.eu/en/documents/product-information/spikevax-previously-covid-19-vaccine-moderna-epar-product-information_en.pdf
3,https://www.ema.europa.eu/en/documents/product-information/clopidogrel-ratiopharm-epar-product-information_en-0.pdf
4,https://www.ema.europa.eu/en/documents/product-information/incruse-ellipta-epar-product-information_en.pdf
5,https://www.ema.europa.eu/en/documents/product-information/stelara-epar-product-information_en.pdf
6,https://www.ema.europa.eu/en/documents/product-information/modigraf-epar-product-information_en.pdf
7,https://www.ema.europa.eu/en/documents/product-information/kengrexal-epar-product-information_en.pdf
8,https://www.ema.europa.eu/en/documents/product-information/hycamtin-epar-product-information_en.pdf
9,https://www.ema.europa.eu/en/documents/product-information/ellaone-epar-product-information_en.pdf
10,https://www.ema.europa.eu/en/documents/product-information/jcovden-previously-covid-19-vaccine-janssen-epar-product-information_en.pdf
11,https://www.ema.europa.eu/en/documents/product-information/enhertu-epar-product-information_en.pdf
12,https://www.ema.europa.eu/en/documents/product-information/advagraf-epar-product-information_en.pdf
13,https://www.ema.europa.eu/en/documents/product-information/plenadren-epar-product-information_en.pdf
14,https://www.ema.europa.eu/en/documents/product-information/herzuma-epar-product-information_en.pdf
15,https://www.ema.europa.eu/en/documents/product-information/iasibon-epar-product-information_en.pdf
16,https://www.ema.europa.eu/en/documents/product-information/fulphila-epar-product-information_en.pdf
17,https://www.ema.europa.eu/en/documents/product-information/teriflunomide-accord-epar-product-information_en.pdf
18,https://www.ema.europa.eu/en/documents/product-information/trumenba-epar-product-information_en.pdf
19,https://www.ema.europa.eu/en/documents/product-information/descovy-epar-product-information_en.pdf
20,https://www.ema.europa.eu/en/documents/product-information/adasuve-epar-product-information_en.pdf
21,https://www.ema.europa.eu/en/documents/product-information/halaven-epar-product-information_en.pdf
22,https://www.ema.europa.eu/en/documents/product-information/blitzima-epar-product-information_en.pdf
23,https://www.ema.europa.eu/en/documents/product-information/exparel-liposomal-epar-product-information_en.pdf
24,https://www.ema.europa.eu/en/documents/product-information/zolgensma-epar-product-information_en.pdf
25,https://www.ema.europa.eu/en/documents/product-information/eylea-epar-product-information_en.pdf
26,https://www.ema.europa.eu/en/documents/product-information/soliris-epar-product-information_en.pdf
27,https://www.ema.europa.eu/en/documents/product-information/aranesp-epar-product-information_en.pdf
28,
29,https://www.ema.europa.eu/en/documents/product-information/somavert-epar-product-information_en.pdf
30,https://www.ema.europa.eu/en/documents/product-information/truxima-epar-product-information_en.pdf
31,https://www.ema.europa.eu/en/documents/product-information/exforge-epar-product-information_en.pdf
32,https://www.ema.europa.eu/en/documents/product-information/emgality-epar-product-information_en.pdf
33,https://www.ema.europa.eu/en/documents/product-information/dafiro-epar-product-information_en.pdf
34,https://www.ema.europa.eu/en/documents/product-information/miglustat-dipharma-epar-product-information_en.pdf
35,https://www.ema.europa.eu/en/documents/product-information/copalia-epar-product-information_en.pdf
36,https://www.ema.europa.eu/en/documents/product-information/vyndaqel-epar-product-information_en.pdf
37,https://www.ema.europa.eu/en/documents/product-information/exforge-hct-epar-product-information_en.pdf
38,https://www.ema.europa.eu/en/documents/product-information/dafiro-hct-epar-product-information_en.pdf
39,https://www.ema.europa.eu/en/documents/product-information/copalia-hct-epar-product-information_en.pdf
40,https://www.ema.europa.eu/en/documents/product-information/quviviq-epar-product-information_en.pdf
41,https://www.ema.europa.eu/en/documents/product-information/arixtra-epar-product-information_en.pdf
42,https://www.ema.europa.eu/en/documents/product-information/effentora-epar-product-information_en.pdf
43,https://www.ema.europa.eu/en/documents/product-information/nexpovio-epar-product-information_en.pdf
44,https://www.ema.europa.eu/en/documents/product-information/harvoni-epar-product-information_en.pdf
45,
46,
47,
48,https://www.ema.europa.eu/en/documents/product-information/nuvaxovid-epar-product-information_en.pdf
49,https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf
50,https://www.ema.europa.eu/en/documents/product-information/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-product-information_en.pdf
51,https://www.ema.europa.eu/en/documents/product-information/aubagio-epar-product-information_en.pdf
52,https://www.ema.europa.eu/en/documents/product-information/emtriva-epar-product-information_en.pdf
53,https://www.ema.europa.eu/en/documents/product-information/odefsey-epar-product-information_en.pdf
54,https://www.ema.europa.eu/en/documents/product-information/hexacima-epar-product-information_en.pdf
55,https://www.ema.europa.eu/en/documents/product-information/hexyon-epar-product-information_en.pdf
56,
57,https://www.ema.europa.eu/en/documents/product-information/rubraca-epar-product-information_en.pdf
58,https://www.ema.europa.eu/en/documents/product-information/akynzeo-epar-product-information_en.pdf
59,https://www.ema.europa.eu/en/documents/product-information/retsevmo-epar-product-information_en.pdf
60,https://www.ema.europa.eu/en/documents/product-information/xaluprine-epar-product-information_en.pdf
61,https://www.ema.europa.eu/en/documents/product-information/kaftrio-epar-product-information_en.pdf
62,https://www.ema.europa.eu/en/documents/product-information/evra-epar-product-information_en.pdf
63,https://www.ema.europa.eu/en/documents/product-information/roctavian-epar-product-information_en.pdf
64,https://www.ema.europa.eu/en/documents/product-information/jyseleca-epar-product-information_en.pdf
65,https://www.ema.europa.eu/en/documents/product-information/tezspire-epar-product-information_en.pdf
66,
67,https://www.ema.europa.eu/en/documents/product-information/dovato-epar-product-information_en.pdf
68,https://www.ema.europa.eu/en/documents/product-information/crysvita-epar-product-information_en.pdf
69,https://www.ema.europa.eu/en/documents/product-information/waylivra-epar-product-information_en.pdf
70,https://www.ema.europa.eu/en/documents/product-information/apexxnar-epar-product-information_en.pdf
71,https://www.ema.europa.eu/en/documents/product-information/eucreas-epar-product-information_en.pdf
72,https://www.ema.europa.eu/en/documents/product-information/veltassa-epar-product-information_en.pdf
73,https://www.ema.europa.eu/en/documents/product-information/helicobacter-test-infai-epar-product-information_en.pdf
74,https://www.ema.europa.eu/en/documents/product-information/triumeq-epar-product-information_en.pdf
75,https://www.ema.europa.eu/en/documents/product-information/tivicay-epar-product-information_en.pdf
76,https://www.ema.europa.eu/en/documents/product-information/juluca-epar-product-information_en.pdf
77,https://www.ema.europa.eu/en/documents/product-information/refacto-af-epar-product-information_en.pdf
78,https://www.ema.europa.eu/en/documents/product-information/xiliarx-epar-product-information_en.pdf
79,https://www.ema.europa.eu/en/documents/product-information/xagrid-epar-product-information_en.pdf
80,https://www.ema.europa.eu/en/documents/product-information/gardasil-epar-product-information_en.pdf
81,
82,https://www.ema.europa.eu/en/documents/product-information/genvoya-epar-product-information_en.pdf
83,https://www.ema.europa.eu/en/documents/product-information/cufence-epar-product-information_en.pdf
84,https://www.ema.europa.eu/en/documents/product-information/pedea-epar-product-information_en.pdf
85,https://www.ema.europa.eu/en/documents/product-information/pecfent-epar-product-information_en.pdf
86,https://www.ema.europa.eu/en/documents/product-information/tegsedi-epar-product-information_en.pdf
87,https://www.ema.europa.eu/en/documents/product-information/evusheld-epar-product-information_en.pdf
88,https://www.ema.europa.eu/en/documents/product-information/pegasys-epar-product-information_en.pdf
89,https://www.ema.europa.eu/en/documents/product-information/vumerity-epar-product-information_en.pdf
90,https://www.ema.europa.eu/en/documents/product-information/kymriah-epar-product-information_en.pdf
91,https://www.ema.europa.eu/en/documents/product-information/vihuma-epar-product-information_en.pdf
92,https://www.ema.europa.eu/en/documents/product-information/nuwiq-epar-product-information_en.pdf
93,https://www.ema.europa.eu/en/documents/product-information/darunavir-mylan-epar-product-information_en.pdf
94,https://www.ema.europa.eu/en/documents/product-information/scenesse-epar-product-information_en.pdf
95,https://www.ema.europa.eu/en/documents/product-information/revolade-epar-product-information_en.pdf
96,https://www.ema.europa.eu/en/documents/product-information/keytruda-epar-product-information_en.pdf
97,https://www.ema.europa.eu/en/documents/product-information/jakavi-epar-product-information_en.pdf
98,https://www.ema.europa.eu/en/documents/product-information/intrarosa-epar-product-information_en.pdf
99,https://www.ema.europa.eu/en/documents/product-information/paxlovid-epar-product-information_en.pdf
100,
101,https://www.ema.europa.eu/en/documents/product-information/veklury-epar-product-information_en.pdf
102,https://www.ema.europa.eu/en/documents/product-information/jemperli-epar-product-information_en.pdf
103,https://www.ema.europa.eu/en/documents/product-information/buccolam-epar-product-information_en.pdf
104,https://www.ema.europa.eu/en/documents/product-information/micardis-epar-product-information_en.pdf
105,
106,https://www.ema.europa.eu/en/documents/product-information/imraldi-epar-product-information_en.pdf
107,https://www.ema.europa.eu/en/documents/product-information/relistor-epar-product-information_en.pdf
108,https://www.ema.europa.eu/en/documents/product-information/vaxneuvance-epar-product-information_en.pdf
109,https://www.ema.europa.eu/en/documents/product-information/edurant-epar-product-information_en.pdf
110,https://www.ema.europa.eu/en/documents/product-information/raxone-epar-product-information_en.pdf
111,https://www.ema.europa.eu/en/documents/product-information/natpar-epar-product-information_en.pdf
112,https://www.ema.europa.eu/en/documents/product-information/lamzede-epar-product-information_en.pdf
113,https://www.ema.europa.eu/en/documents/product-information/myalepta-epar-product-information_en.pdf
114,https://www.ema.europa.eu/en/documents/product-information/sitagliptin-sun-epar-product-information_en.pdf
115,https://www.ema.europa.eu/en/documents/product-information/galvus-epar-product-information_en.pdf
116,https://www.ema.europa.eu/en/documents/product-information/tasigna-epar-product-information_en.pdf
117,https://www.ema.europa.eu/en/documents/product-information/obizur-epar-product-information_en.pdf
118,https://www.ema.europa.eu/en/documents/product-information/ibrance-epar-product-information_en.pdf
119,https://www.ema.europa.eu/en/documents/product-information/mvasi-epar-product-information_en.pdf
120,https://www.ema.europa.eu/en/documents/product-information/dzuveo-epar-product-information_en.pdf
121,https://www.ema.europa.eu/en/documents/product-information/xeloda-epar-product-information_en.pdf
122,https://www.ema.europa.eu/en/documents/product-information/roactemra-epar-product-information_en.pdf
123,https://www.ema.europa.eu/en/documents/product-information/cometriq-epar-product-information_en.pdf
124,https://www.ema.europa.eu/en/documents/product-information/esperoct-epar-product-information_en.pdf
125,https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_en.pdf
126,
127,https://www.ema.europa.eu/en/documents/product-information/invanz-epar-product-information_en.pdf
128,https://www.ema.europa.eu/en/documents/product-information/prialt-epar-product-information_en.pdf
129,https://www.ema.europa.eu/en/documents/product-information/velmetia-epar-product-information_en.pdf
130,https://www.ema.europa.eu/en/documents/product-information/xelevia-epar-product-information_en.pdf
131,
132,https://www.ema.europa.eu/en/documents/product-information/vemlidy-epar-product-information_en.pdf
133,https://www.ema.europa.eu/en/documents/product-information/dasatinib-accordpharma-epar-product-information_en.pdf
134,https://www.ema.europa.eu/en/documents/product-information/opdivo-epar-product-information_en.pdf
135,https://www.ema.europa.eu/en/documents/product-information/yervoy-epar-product-information_en.pdf
136,https://www.ema.europa.eu/documents/product-information/fingolimod-mylan-epar-product-information_en.pdf
137,https://www.ema.europa.eu/en/documents/product-information/imvanex-epar-product-information_en.pdf
138,https://www.ema.europa.eu/en/documents/product-information/kalydeco-epar-product-information_en.pdf
139,https://www.ema.europa.eu/en/documents/product-information/vazkepa-epar-product-infomartion_en.pdf
140,https://www.ema.europa.eu/en/documents/product-information/jinarc-epar-product-information_en.pdf
141,https://www.ema.europa.eu/en/documents/product-information/iclusig-epar-product-information_en.pdf
142,https://www.ema.europa.eu/en/documents/product-information/siklos-epar-product-information_en.pdf
143,https://www.ema.europa.eu/en/documents/product-information/ogluo-epar-product-information_en.pdf
144,https://www.ema.europa.eu/en/documents/product-information/firazyr-epar-product-information_en.pdf
145,https://www.ema.europa.eu/en/documents/product-information/vpriv-epar-product-information_en.pdf
146,https://www.ema.europa.eu/en/documents/product-information/thalidomide-lipomed-epar-product-information_en.pdf
147,https://www.ema.europa.eu/en/documents/product-information/lorviqua-epar-product-information_en.pdf
148,https://www.ema.europa.eu/en/documents/product-information/isentress-epar-product-information_en.pdf
149,https://www.ema.europa.eu/en/documents/product-information/ravicti-epar-product-information_en.pdf
150,https://www.ema.europa.eu/en/documents/product-information/tecvayli-epar-product-information_en.pdf
151,https://www.ema.europa.eu/en/documents/product-information/invirase-epar-product-information_en.pdf
152,https://www.ema.europa.eu/en/documents/product-information/nexavar-epar-product-information_en.pdf
153,https://www.ema.europa.eu/en/documents/product-information/bavencio-epar-product-information_en.pdf
154,https://www.ema.europa.eu/en/documents/product-information/vocabria-epar-product-information_en.pdf
155,https://www.ema.europa.eu/en/documents/product-information/idacio-epar-product-information_en.pdf
156,https://www.ema.europa.eu/en/documents/product-information/saphnelo-epar-product-information_en.pdf
157,https://www.ema.europa.eu/en/documents/product-information/tecartus-epar-product-information_en.pdf
158,https://www.ema.europa.eu/en/documents/product-information/rasagiline-mylan-epar-product-information_en.pdf
159,https://www.ema.europa.eu/en/documents/product-information/evrenzo-epar-product-information_en.pdf
160,https://www.ema.europa.eu/en/documents/product-information/pregabalin-mylan-epar-product-information_en.pdf
161,https://www.ema.europa.eu/en/documents/product-information/veraseal-epar-product-information_en.pdf
162,https://www.ema.europa.eu/en/documents/product-information/norvir-epar-product-information_en.pdf
163,https://www.ema.europa.eu/en/documents/product-information/lonquex-epar-product-information_en.pdf
164,https://www.ema.europa.eu/en/documents/product-information/deltyba-epar-product-information_en.pdf
165,https://www.ema.europa.eu/en/documents/product-information/trazimera-epar-product-information_en.pdf
166,https://www.ema.europa.eu/en/documents/product-information/reyataz-epar-product-information_en.pdf
167,https://www.ema.europa.eu/en/documents/product-information/xevudy-epar-product-information_en.pdf
168,https://www.ema.europa.eu/en/documents/product-information/opdualag-epar-product-information_en.pdf
169,https://www.ema.europa.eu/documents/product-information/takhzyro-epar-product-information_en.pdf
170,https://www.ema.europa.eu/en/documents/product-information/trogarzo-epar-product-information_en.pdf
171,https://www.ema.europa.eu/en/documents/product-information/sustiva-epar-product-information_en.pdf
172,https://www.ema.europa.eu/en/documents/product-information/benefix-epar-product-information_en.pdf
173,https://www.ema.europa.eu/en/documents/product-information/repatha-epar-product-information_en.pdf
174,https://www.ema.europa.eu/en/documents/product-information/ilumetri-epar-product-information_en.pdf
175,https://www.ema.europa.eu/en/documents/product-information/nplate-epar-product-information_en.pdf
176,https://www.ema.europa.eu/en/documents/product-information/memantine-mylan-epar-product-information_en.pdf
177,https://www.ema.europa.eu/en/documents/product-information/vimpat-epar-product-information_en.pdf
178,https://www.ema.europa.eu/en/documents/product-information/humira-epar-product-information_en.pdf
179,https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product-information_en.pdf
180,https://www.ema.europa.eu/en/documents/product-information/quofenix-epar-product-information_en.pdf
181,https://www.ema.europa.eu/en/documents/product-information/kaletra-epar-product-information_en.pdf
182,
183,https://www.ema.europa.eu/en/documents/product-information/vabysmo-epar-product-information_en.pdf
184,https://www.ema.europa.eu/en/documents/product-information/brintellix-epar-product-information_en.pdf
185,https://www.ema.europa.eu/en/documents/product-information/fycompa-epar-product-information_en.pdf
186,https://www.ema.europa.eu/en/documents/product-information/oxlumo-epar-product-information_en.pdf
187,https://www.ema.europa.eu/en/documents/product-information/rivastigmine-sandoz-epar-product-information_en.pdf
188,https://www.ema.europa.eu/en/documents/product-information/rivastigmine-hexal-epar-product-information_en.pdf
189,https://www.ema.europa.eu/en/documents/product-information/rekambys-epar-product-information_en.pdf
190,https://www.ema.europa.eu/en/documents/product-information/benepali-epar-product-information_en.pdf
191,https://www.ema.europa.eu/en/documents/product-information/cancidas-epar-product-information_en.pdf
192,https://www.ema.europa.eu/en/documents/product-information/karvea-epar-product-information_en.pdf
193,https://www.ema.europa.eu/documents/product-information/orladeyo-epar-product-information_en.pdf
194,https://www.ema.europa.eu/en/documents/product-information/aprovel-epar-product-information_en.pdf
195,https://www.ema.europa.eu/documents/product-information/evkeeza-epar-product-information_en.pdf
196,https://www.ema.europa.eu/en/documents/product-information/byfavo-epar-product-information_en.pdf
197,https://www.ema.europa.eu/en/documents/product-information/ritonavir-mylan-epar-product-information_en.pdf
198,https://www.ema.europa.eu/en/documents/product-information/sunosi-epar-product-information_en.pdf
199,https://www.ema.europa.eu/en/documents/product-information/amvuttra-epar-product-information_en.pdf
200,https://www.ema.europa.eu/en/documents/product-information/bexsero-epar-product-information_en.pdf
201,
202,https://www.ema.europa.eu/en/documents/product-information/blenrep-epar-product-information_en.pdf
203,https://www.ema.europa.eu/en/documents/product-information/xyrem-epar-product-information_en.pdf
204,https://www.ema.europa.eu/en/documents/product-information/azarga-epar-product-information_en.pdf
205,https://www.ema.europa.eu/en/documents/product-information/lucentis-epar-product-information_en.pdf
206,https://www.ema.europa.eu/en/documents/product-information/nucala-epar-product-information_en.pdf
207,https://www.ema.europa.eu/en/documents/product-information/tygacil-epar-product-information_en.pdf
208,https://www.ema.europa.eu/en/documents/product-information/avonex-epar-product-information_en.pdf
209,https://www.ema.europa.eu/documents/product-information/cibinqo-epar-product-information_en.pdf
210,https://www.ema.europa.eu/en/documents/product-information/privigen-epar-product-information_en.pdf
211,https://www.ema.europa.eu/documents/product-information/pifeltro-epar-product-information_en.pdf
212,https://www.ema.europa.eu/documents/product-information/delstrigo-epar-product-information_en.pdf
213,https://www.ema.europa.eu/en/documents/product-information/hetlioz-epar-product-information_en.pdf
214,https://www.ema.europa.eu/en/documents/product-information/entyvio-epar-product-information_en.pdf
215,https://www.ema.europa.eu/en/documents/product-information/granupas-epar-product-information_en.pdf
216,https://www.ema.europa.eu/en/documents/product-information/vaxelis-epar-product-information_en.pdf
217,https://www.ema.europa.eu/en/documents/product-information/atectura-breezhaler-epar-product-information_en.pdf
218,https://www.ema.europa.eu/en/documents/product-information/silodyx-epar-product-information_en.pdf
219,https://www.ema.europa.eu/en/documents/product-information/cinryze-epar-product-information_en.pdf
220,https://www.ema.europa.eu/en/documents/product-information/olanzapine-apotex-epar-product-information_en.pdf
221,https://www.ema.europa.eu/en/documents/product-information/revinty-ellipta-epar-product-information_en.pdf
222,https://www.ema.europa.eu/en/documents/product-information/relvar-ellipta-epar-product-information_en.pdf
223,
224,https://www.ema.europa.eu/en/documents/product-information/prolia-epar-product-information_en.pdf
225,https://www.ema.europa.eu/en/documents/product-information/bylvay-epar-product-information_en.pdf
226,https://www.ema.europa.eu/en/documents/product-information/jorveza-epar-product-information_en.pdf
227,https://www.ema.europa.eu/en/documents/product-information/tookad-epar-product-information_en.pdf
228,
229,https://www.ema.europa.eu/en/documents/product-information/stocrin-epar-product-information_en.pdf
230,https://www.ema.europa.eu/en/documents/product-information/ranivisio-epar-product-information_en.pdf
231,https://www.ema.europa.eu/en/documents/product-information/lenalidomide-mylan-epar-product-information_en.pdf
232,https://www.ema.europa.eu/en/documents/product-information/ferriprox-epar-product-information_en.pdf
233,https://www.ema.europa.eu/en/documents/product-information/heplisav-b-epar-product-information_en.pdf
234,https://www.ema.europa.eu/en/documents/product-information/intuniv-epar-product-information_en.pdf
235,https://www.ema.europa.eu/en/documents/product-information/neoclarityn-epar-product-information_en.pdf
236,https://www.ema.europa.eu/en/documents/product-information/aerius-epar-product-information_en.pdf
237,https://www.ema.europa.eu/en/documents/product-information/azomyr-epar-product-information_en.pdf
238,https://www.ema.europa.eu/en/documents/product-information/xeljanz-epar-product-information_en.pdf
239,https://www.ema.europa.eu/en/documents/product-information/firmagon-epar-product-information_en.pdf
240,https://www.ema.europa.eu/en/documents/product-information/tagrisso-epar-product-information_en.pdf
241,https://www.ema.europa.eu/en/documents/product-information/lynparza-epar-product-information_en.pdf
242,https://www.ema.europa.eu/en/documents/product-information/sarclisa-epar-product-information_en.pdf
243,https://www.ema.europa.eu/en/documents/product-information/ocrevus-epar-product-information_en.pdf
244,https://www.ema.europa.eu/en/documents/product-information/rayvow-epar-product-information_en.pdf
245,https://www.ema.europa.eu/documents/product-information/sugammadex-mylan-epar-product-information_en.pdf
246,https://www.ema.europa.eu/en/documents/product-information/aflunov-epar-product-information_en.pdf
247,https://www.ema.europa.eu/en/documents/product-information/febuxostat-mylan-epar-product-information_en.pdf
248,https://www.ema.europa.eu/en/documents/product-information/vydura-epar-product-information_en.pdf
249,https://www.ema.europa.eu/en/documents/product-information/ertapenem-sun-epar-product-information_en.pdf
250,
251,
252,https://www.ema.europa.eu/en/documents/product-information/dimethyl-fumarate-mylan-epar-product-information_en.pdf
253,https://www.ema.europa.eu/documents/product-information/ogivri-epar-product-information_en.pdf
254,
255,
256,https://www.ema.europa.eu/en/documents/product-information/irbesartan-hydrochlorothiazide-zentiva-epar-product-information_en.pdf
257,https://www.ema.europa.eu/en/documents/product-information/fasenra-epar-product-information_en.pdf
258,https://www.ema.europa.eu/en/documents/product-information/vyvgart-epar-product-information_en.pdf
259,https://www.ema.europa.eu/en/documents/product-information/irbesartan-zentiva-epar-product-information_en.pdf
260,https://www.ema.europa.eu/en/documents/product-information/obiltoxaximab-sfl-epar-product-information_en.pdf
261,https://www.ema.europa.eu/en/documents/product-information/remsima-epar-product-information_en.pdf
262,https://www.ema.europa.eu/en/documents/product-information/ozempic-epar-product-information_en.pdf
263,https://www.ema.europa.eu/en/documents/product-information/skilarence-epar-product-information_en.pdf
264,https://www.ema.europa.eu/en/documents/product-information/lemtrada-epar-product-information_en.pdf
265,https://www.ema.europa.eu/en/documents/product-information/tukysa-epar-product-information_en.pdf
266,https://www.ema.europa.eu/en/documents/product-information/trizivir-epar-product-information_en.pdf
267,https://www.ema.europa.eu/en/documents/product-information/hemlibra-epar-product-information_en.pdf
268,https://www.ema.europa.eu/en/documents/product-information/vaxchora-epar-product-information_en.pdf
269,https://www.ema.europa.eu/en/documents/product-information/reblozyl-epar-product-information_en.pdf
270,https://www.ema.europa.eu/en/documents/product-information/vaniqa-epar-product-information_en.pdf
271,https://www.ema.europa.eu/en/documents/product-information/rybrevant-epar-product-information_en.pdf
272,
273,https://www.ema.europa.eu/en/documents/product-information/methylthioninium-chloride-proveblue-epar-product-information_en.pdf
274,https://www.ema.europa.eu/en/documents/product-information/atazanavir-mylan-epar-product-information_en.pdf
275,https://www.ema.europa.eu/en/documents/product-information/rixubis-epar-product-information_en.pdf
276,https://www.ema.europa.eu/en/documents/product-information/nivestim-epar-product-information_en.pdf
277,https://www.ema.europa.eu/en/documents/product-information/remicade-epar-product-information_en.pdf
278,https://www.ema.europa.eu/documents/product-information/epidyolex-epar-product-information_en.pdf
279,https://www.ema.europa.eu/en/documents/product-information/kadcyla-epar-product-information_en.pdf
280,https://www.ema.europa.eu/en/documents/product-information/rydapt-epar-product-information_en.pdf
281,https://www.ema.europa.eu/en/documents/product-information/elzonris-epar-product-information_en.pdf
282,https://www.ema.europa.eu/en/documents/product-information/metalyse-epar-product-information_en.pdf
283,https://www.ema.europa.eu/en/documents/product-information/posaconazole-accord-epar-product-information_en.pdf
284,https://www.ema.europa.eu/en/documents/product-information/libtayo-epar-product-information_en.pdf
285,https://www.ema.europa.eu/en/documents/product-information/hulio-epar-product-information_en.pdf
286,https://www.ema.europa.eu/en/documents/product-information/blincyto-epar-product-information_en.pdf
287,https://www.ema.europa.eu/en/documents/product-information/ruxience-epar-product-information_en.pdf
288,
289,https://www.ema.europa.eu/en/documents/product-information/komboglyze-epar-product-information_en.pdf
290,https://www.ema.europa.eu/en/documents/product-information/onglyza-epar-product-information_en.pdf
291,https://www.ema.europa.eu/en/documents/product-information/nyxoid-epar-product-information_en.pdf
292,https://www.ema.europa.eu/en/documents/product-information/imbruvica-epar-product-information_en.pdf
293,https://www.ema.europa.eu/en/documents/product-information/rinvoq-epar-product-information_en.pdf
294,https://www.ema.europa.eu/en/documents/product-information/polivy-epar-product-information_en.pdf
295,https://www.ema.europa.eu/en/documents/product-information/vitrakvi-epar-product-information_en.pdf
296,https://www.ema.europa.eu/en/documents/product-information/qarziba-epar-product-information_en.pdf
297,https://www.ema.europa.eu/en/documents/product-information/lutetium-177lu-chloride-billev-previously-illuzyce-epar-product-information_en.pdf
298,https://www.ema.europa.eu/en/documents/product-information/tabrecta-epar-product-information_en.pdf
299,
300,https://www.ema.europa.eu/en/documents/product-information/lupkynis-epar-product-information_en.pdf
301,https://www.ema.europa.eu/en/documents/product-information/carmustine-obvius-epar-product-information_en.pdf
302,https://www.ema.europa.eu/en/documents/product-information/ontruzant-epar-product-information_en.pdf
303,https://www.ema.europa.eu/en/documents/product-information/replagal-epar-product-information_en.pdf
304,https://www.ema.europa.eu/en/documents/product-information/fortacin-epar-product-information_en.pdf
305,
306,https://www.ema.europa.eu/en/documents/product-information/palforzia-epar-product-information_en.pdf
307,https://www.ema.europa.eu/en/documents/product-information/envarsus-epar-product-information_en.pdf
308,https://www.ema.europa.eu/en/documents/product-information/nepexto-epar-product-information_en.pdf
309,https://www.ema.europa.eu/en/documents/product-information/intelence-epar-product-information_en.pdf
310,https://www.ema.europa.eu/en/documents/product-information/instanyl-epar-product-information_en.pdf
311,
312,https://www.ema.europa.eu/en/documents/product-information/sialanar-epar-product-information_en.pdf
313,https://www.ema.europa.eu/en/documents/product-information/yellox-epar-product-information_en.pdf
314,https://www.ema.europa.eu/en/documents/product-information/ilaris-epar-product-information_en.pdf
315,https://www.ema.europa.eu/en/documents/product-information/symtuza-epar-product-information_en.pdf
316,
317,
318,https://www.ema.europa.eu/en/documents/product-information/kinzalkomb-epar-product-information_en.pdf
319,https://www.ema.europa.eu/en/documents/product-information/tysabri-epar-product-information_en.pdf
320,https://www.ema.europa.eu/en/documents/product-information/aripiprazole-mylan-pharma-epar-product-information_en.pdf
321,https://www.ema.europa.eu/en/documents/product-information/cinacalcet-mylan-epar-product-information_en.pdf
322,https://www.ema.europa.eu/en/documents/product-information/libmeldy-epar-product-information_en.pdf
323,https://www.ema.europa.eu/en/documents/product-information/tavlesse-epar-product-information_en.pdf
324,https://www.ema.europa.eu/documents/product-information/apealea-epar-product-information_en.pdf
325,https://www.ema.europa.eu/en/documents/product-information/vipdomet-epar-product-information_en.pdf
326,https://www.ema.europa.eu/en/documents/product-information/vipidia-epar-product-information_en.pdf
327,https://www.ema.europa.eu/en/documents/product-information/incresync-epar-product-information_en.pdf
328,https://www.ema.europa.eu/en/documents/product-information/erelzi-epar-product-information_en.pdf
329,https://www.ema.europa.eu/en/documents/product-information/eliquis-epar-product-information_en.pdf
330,https://www.ema.europa.eu/en/documents/product-information/procysbi-epar-product-information_en.pdf
331,https://www.ema.europa.eu/en/documents/product-information/ontozry-epar-product-information_en.pdf
332,https://www.ema.europa.eu/en/documents/product-information/tepadina-epar-product-information_en.pdf
333,https://www.ema.europa.eu/en/documents/product-information/scemblix-epar-product-information_en.pdf
334,https://www.ema.europa.eu/en/documents/product-information/zerbaxa-epar-product-information_en.pdf
335,
336,https://www.ema.europa.eu/en/documents/product-information/jardiance-epar-product-information_en.pdf
337,https://www.ema.europa.eu/en/documents/product-information/gonal-f-epar-product-information_en.pdf
338,https://www.ema.europa.eu/en/documents/product-information/luveris-epar-product-information_en.pdf
339,https://www.ema.europa.eu/en/documents/product-information/inhixa-epar-product-information_en.pdf
340,https://www.ema.europa.eu/en/documents/product-information/praluent-epar-product-information_en.pdf
341,https://www.ema.europa.eu/en/documents/product-information/aspaveli-epar-product-information_en.pdf
342,https://www.ema.europa.eu/en/documents/product-information/ngenla-epar-product-information_en.pdf
343,https://www.ema.europa.eu/en/documents/product-information/fetcroja-epar-product-information_en.pdf
344,https://www.ema.europa.eu/en/documents/product-information/suliqua-epar-product-information_en.pdf
345,https://www.ema.europa.eu/en/documents/product-information/neparvis-epar-product-information_en.pdf
346,https://www.ema.europa.eu/en/documents/product-information/entresto-epar-product-information_en.pdf
347,https://www.ema.europa.eu/en/documents/product-information/prevymis-epar-product-information_en.pdf
348,https://www.ema.europa.eu/en/documents/product-information/insuman-epar-product-information_en.pdf
349,https://www.ema.europa.eu/en/documents/product-information/sitagliptin/metformin-hydrochloride-accord-epar-product-information_en.pdf
350,https://www.ema.europa.eu/en/documents/product-information/imfinzi-epar-product-information_en.pdf
351,https://www.ema.europa.eu/en/documents/product-information/exjade-epar-product-information_en.pdf
352,
353,https://www.ema.europa.eu/en/documents/product-information/riximyo-epar-product-information_en.pdf
354,https://www.ema.europa.eu/en/documents/product-information/rixathon-epar-product-information_en.pdf
355,https://www.ema.europa.eu/en/documents/product-information/xermelo-epar-product-information_en.pdf
356,https://www.ema.europa.eu/en/documents/product-information/faslodex-epar-product-information_en.pdf
357,https://www.ema.europa.eu/en/documents/product-information/mabthera-epar-product-information_en.pdf
358,https://www.ema.europa.eu/en/documents/product-information/piqray-epar-product-information_en.pdf
359,https://www.ema.europa.eu/en/documents/product-information/zutectra-epar-product-information_en.pdf
360,https://www.ema.europa.eu/en/documents/product-information/prometax-epar-product-information_en.pdf
361,https://www.ema.europa.eu/en/documents/product-information/skyrizi-epar-product-information_en.pdf
362,https://www.ema.europa.eu/en/documents/product-information/exelon-epar-product-information_en.pdf
363,https://www.ema.europa.eu/en/documents/product-information/emend-epar-product-information_en.pdf
364,https://www.ema.europa.eu/en/documents/product-information/cerezyme-epar-product-information_en.pdf
365,https://www.ema.europa.eu/en/documents/product-information/spravato-epar-product-information_en.pdf
366,
367,https://www.ema.europa.eu/en/documents/product-information/pregabalin-pfizer-epar-product-information_en.pdf
368,https://www.ema.europa.eu/en/documents/product-information/lacosamide-accord-epar-product-information_en.pdf
369,https://www.ema.europa.eu/en/documents/product-information/viagra-epar-product-information_en.pdf
370,https://www.ema.europa.eu/en/documents/product-information/hepcludex-epar-product-information_en.pdf
371,https://www.ema.europa.eu/en/documents/product-information/ziagen-epar-product-information_en.pdf
372,https://www.ema.europa.eu/en/documents/product-information/epivir-epar-product-information_en.pdf
373,https://www.ema.europa.eu/en/documents/product-information/combivir-epar-product-information_en.pdf
374,https://www.ema.europa.eu/en/documents/product-information/ivemend-epar-product-information_en.pdf
375,https://www.ema.europa.eu/en/documents/product-information/bydureon-epar-product-information_en.pdf
376,https://www.ema.europa.eu/en/documents/product-information/aripiprazole-zentiva-epar-product-information_en.pdf
377,
378,https://www.ema.europa.eu/en/documents/product-information/synflorix-epar-product-information_en.pdf
379,https://www.ema.europa.eu/en/documents/product-information/abevmy-epar-product-information_en.pdf
380,https://www.ema.europa.eu/en/documents/product-information/ontilyv-epar-product-information_en.pdf
381,https://www.ema.europa.eu/en/documents/product-information/sunlenca-epar-product-information_en.pdf
382,https://www.ema.europa.eu/en/documents/product-information/daxas-epar-product-information_en.pdf
383,https://www.ema.europa.eu/en/documents/product-information/pemetrexed-krka-epar-product-information_en.pdf
384,https://www.ema.europa.eu/en/documents/product-information/byetta-epar-product-information_en.pdf
385,https://www.ema.europa.eu/en/documents/product-information/armisarte-epar-product-information_en.pdf
386,https://www.ema.europa.eu/en/documents/product-information/revatio-epar-product-information_en.pdf
387,https://www.ema.europa.eu/en/documents/product-information/lyrica-epar-product-information_en.pdf
388,
389,https://www.ema.europa.eu/en/documents/product-information/koselugo-epar-product-information_en.pdf
390,
391,https://www.ema.europa.eu/en/documents/product-information/tecentriq-epar-product-information_en.pdf
392,
393,https://www.ema.europa.eu/en/documents/product-information/opatanol-epar-product-information_en.pdf
394,https://www.ema.europa.eu/en/documents/product-information/nordimet-epar-product-information_en.pdf
395,https://www.ema.europa.eu/en/documents/product-information/maviret-epar-product-information_en.pdf
396,https://www.ema.europa.eu/en/documents/product-information/telzir-epar-product-information_en.pdf
397,https://www.ema.europa.eu/en/documents/product-information/constella-epar-product-information_en.pdf
398,https://www.ema.europa.eu/en/documents/product-information/kivexa-epar-product-information_en.pdf
399,https://www.ema.europa.eu/en/documents/product-information/aptivus-epar-product-information_en.pdf
400,https://www.ema.europa.eu/en/documents/product-information/viramune-epar-product-information_en.pdf
401,https://www.ema.europa.eu/en/documents/product-information/rukobia-epar-product-information_en.pdf
402,https://www.ema.europa.eu/en/documents/product-information/celsentri-epar-product-information_en.pdf
403,https://www.ema.europa.eu/en/documents/product-information/ivabradine-zentiva-epar-product-information_en.pdf
404,https://www.ema.europa.eu/en/documents/product-information/sovaldi-epar-product-information_en.pdf
405,https://www.ema.europa.eu/en/documents/product-information/cuprior-epar-product-information_en.pdf
406,https://www.ema.europa.eu/en/documents/product-information/spherox-epar-product-information_en.pdf
407,https://www.ema.europa.eu/en/documents/product-information/nexobrid-epar-product-information_en.pdf
408,https://www.ema.europa.eu/en/documents/product-information/forxiga-epar-product-information_en.pdf
409,https://www.ema.europa.eu/documents/product-information/luxturna-epar-product-information_en.pdf
410,https://www.ema.europa.eu/en/documents/product-information/tacforius-epar-product-information_en.pdf
411,https://www.ema.europa.eu/en/documents/product-information/leqvio-epar-product-information_en.pdf
412,https://www.ema.europa.eu/en/documents/product-information/posaconazole-ahcl-epar-product-information_en.pdf
413,https://www.ema.europa.eu/en/documents/product-information/resolor-epar-product-information_en.pdf
414,https://www.ema.europa.eu/en/documents/product-information/yselty-epar-product-information_en.pdf
415,https://www.ema.europa.eu/en/documents/product-information/venclyxto-epar-product-information_en.pdf
416,https://www.ema.europa.eu/en/documents/product-information/pergoveris-epar-product-information_en.pdf
417,https://www.ema.europa.eu/en/documents/product-information/dynastat-epar-product-information_en.pdf
418,https://www.ema.europa.eu/en/documents/product-information/ciambra-epar-product-information_en.pdf
419,https://www.ema.europa.eu/en/documents/product-information/orgovyx-epar-product-information_en.pdf
420,https://www.ema.europa.eu/en/documents/product-information/prezista-epar-product-information_en.pdf
421,https://www.ema.europa.eu/en/documents/product-information/duloxetine-zentiva-epar-product-information_en.pdf
422,https://www.ema.europa.eu/en/documents/product-information/lokelma-epar-product-information_en.pdf
423,https://www.ema.europa.eu/en/documents/product-information/brineura-epar-product-information_en.pdf
424,https://www.ema.europa.eu/en/documents/product-information/hbvaxpro-epar-product-information_en.pdf
425,https://www.ema.europa.eu/en/documents/product-information/rotateq-epar-product-information_en.pdf
426,https://www.ema.europa.eu/en/documents/product-information/exviera-epar-product-information_en.pdf
427,https://www.ema.europa.eu/en/documents/product-information/viekirax-epar-product-information_en.pdf
428,https://www.ema.europa.eu/en/documents/product-information/sifrol-epar-product-information_en.pdf
429,https://www.ema.europa.eu/en/documents/product-information/mirapexin-epar-product-information_en.pdf
430,https://www.ema.europa.eu/en/documents/product-information/alecensa-epar-product-information_en.pdf
431,https://www.ema.europa.eu/en/documents/product-information/ranexa-epar-product-information_en.pdf
432,https://www.ema.europa.eu/en/documents/product-information/grasustek-epar-product-information_en.pdf
433,https://www.ema.europa.eu/en/documents/product-information/gliolan-epar-product-information_en.pdf
434,https://www.ema.europa.eu/en/documents/product-information/adenuric-epar-product-information_en.pdf
435,https://www.ema.europa.eu/en/documents/product-information/pemetrexed-medac-epar-product-information_en.pdf
436,https://www.ema.europa.eu/en/documents/product-information/zejula-epar-product-information_en.pdf
437,https://www.ema.europa.eu/en/documents/product-information/gilenya-epar-product-information_en.pdf
438,https://www.ema.europa.eu/en/documents/product-information/signifor-epar-product-information_en.pdf
439,https://www.ema.europa.eu/en/documents/product-information/thymanax-epar-product-information_en.pdf
440,https://www.ema.europa.eu/en/documents/product-information/esbriet-epar-product-information_en.pdf
441,https://www.ema.europa.eu/en/documents/product-information/valdoxan-epar-product-information_en.pdf
442,https://www.ema.europa.eu/en/documents/product-information/braftovi-epar-product-information_en.pdf
443,https://www.ema.europa.eu/en/documents/product-information/cyramza-epar-product-information_en.pdf
444,https://www.ema.europa.eu/en/documents/product-information/myclausen-epar-product-information_en.pdf
445,https://www.ema.europa.eu/en/documents/product-information/topotecan-hospira-epar-product-information_en.pdf
446,https://www.ema.europa.eu/en/documents/product-information/elaprase-epar-product-information_en.pdf
447,https://www.ema.europa.eu/en/documents/product-information/ervebo-epar-product-information_en.pdf
448,https://www.ema.europa.eu/en/documents/product-information/clopidogrel-viatris-epar-product-information_en.pdf
449,https://www.ema.europa.eu/en/documents/product-information/rezolsta-epar-product-information_en.pdf
450,https://www.ema.europa.eu/en/documents/product-information/cosentyx-epar-product-information_en.pdf
451,https://www.ema.europa.eu/en/documents/product-information/clopidogrel/acetylsalicylic-acid-mylan-epar-product-information_en.pdf
452,
453,https://www.ema.europa.eu/en/documents/product-information/bonviva-epar-product-information_en.pdf
454,https://www.ema.europa.eu/en/documents/product-information/fluad-tetra-epar-product-information_en.pdf
455,https://www.ema.europa.eu/en/documents/product-information/zokinvy-epar-product-information_en.pdf
456,https://www.ema.europa.eu/en/documents/product-information/xofluza-epar-product-information_en.pdf
457,https://www.ema.europa.eu/en/documents/product-information/fluenz-tetra-epar-product-information_en.pdf
458,https://www.ema.europa.eu/en/documents/product-information/flucelvax-tetra-epar-product-information_en.pdf
459,https://www.ema.europa.eu/en/documents/product-information/okedi-epar-product-information_en.pdf
460,https://www.ema.europa.eu/en/documents/product-information/strimvelis-epar-product-information_en.pdf
461,https://www.ema.europa.eu/en/documents/product-information/renvela-epar-product-information_en.pdf
462,https://www.ema.europa.eu/en/documents/product-information/vosevi-epar-product-information_en.pdf
463,https://www.ema.europa.eu/en/documents/product-information/sogroya-epar-product-information_en.pdf
464,https://www.ema.europa.eu/en/documents/product-information/zubsolv-epar-product-information_en.pdf
465,https://www.ema.europa.eu/en/documents/product-information/entecavir-mylan-epar-product-information_en.pdf
466,https://www.ema.europa.eu/en/documents/product-information/entecavir-accord-epar-product-information_en.pdf
467,https://www.ema.europa.eu/en/documents/product-information/cresemba-epar-product-information_en.pdf
468,https://www.ema.europa.eu/en/documents/product-information/vaborem-epar-product-information_en.pdf
469,https://www.ema.europa.eu/en/documents/product-information/regkirona-epar-product-information_en.pdf
470,https://www.ema.europa.eu/en/documents/product-information/xydalba-epar-product-information_en.pdf
471,https://www.ema.europa.eu/en/documents/product-information/tigecycline-accord-epar-product-information_en.pdf
472,https://www.ema.europa.eu/en/documents/product-information/yuflyma-epar-product-information_en.pdf
473,
474,
475,https://www.ema.europa.eu/en/documents/product-information/hukyndra-epar-product-information_en.pdf
476,https://www.ema.europa.eu/en/documents/product-information/ryeqo-epar-product-information_en.pdf
477,
478,https://www.ema.europa.eu/en/documents/product-information/xenpozyme-epar-product-information_en.pdf
479,
480,https://www.ema.europa.eu/en/documents/product-information/grepid-epar-product-information_en.pdf
481,https://www.ema.europa.eu/en/documents/product-information/zirabev-epar-product-information_en.pdf
482,https://www.ema.europa.eu/en/documents/product-information/granpidam-epar-product-information_en.pdf
483,https://www.ema.europa.eu/en/documents/product-information/rybelsus-epar-product-information_en.pdf
484,https://www.ema.europa.eu/documents/product-information/fintepla-epar-product-information_en.pdf
485,https://www.ema.europa.eu/en/documents/product-information/rhokiinsa-epar-product-information_en.pdf
486,https://www.ema.europa.eu/en/documents/product-information/cablivi-epar-product-information_en.pdf
487,https://www.ema.europa.eu/en/documents/product-information/lacosamide-ucb-epar-product-information_en.pdf
488,https://www.ema.europa.eu/en/documents/product-information/kisqali-epar-product-information_en.pdf
489,https://www.ema.europa.eu/documents/product-information/ziextenzo-epar-product-information_en.pdf
490,https://www.ema.europa.eu/en/documents/product-information/novoseven-epar-product-information_en.pdf
491,https://www.ema.europa.eu/en/documents/product-information/kovaltry-epar-product-information_en.pdf
492,https://www.ema.europa.eu/en/documents/product-information/revestive-epar-product-information_en.pdf
493,https://www.ema.europa.eu/en/documents/product-information/fotivda-epar-product-information_en.pdf
494,https://www.ema.europa.eu/en/documents/product-information/pradaxa-epar-product-information_en.pdf
495,https://www.ema.europa.eu/en/documents/product-information/afstyla-epar-product-information_en.pdf
496,https://www.ema.europa.eu/en/documents/product-information/uplizna-epar-product-information_en.pdf
497,https://www.ema.europa.eu/en/documents/product-information/vyepti-epar-product-information_en.pdf
498,https://www.ema.europa.eu/en/documents/product-information/orkambi-epar-product-information_en.pdf
499,https://www.ema.europa.eu/en/documents/product-information/trelegy-ellipta-epar-product-information_en.pdf
500,https://www.ema.europa.eu/en/documents/product-information/mayzent-epar-product-information_en.pdf
501,https://www.ema.europa.eu/en/documents/product-information/elebrato-ellipta-epar-product-information_en.pdf
502,https://www.ema.europa.eu/en/documents/product-information/rapamune-epar-product-information_en.pdf
503,https://www.ema.europa.eu/en/documents/product-information/tremfya-epar-product-information_en.pdf
504,https://www.ema.europa.eu/en/documents/product-information/moventig-epar-product-information_en.pdf
505,https://www.ema.europa.eu/en/documents/product-information/proquad-epar-product-information_en.pdf
506,https://www.ema.europa.eu/en/documents/product-information/mekinist-epar-product-information_en.pdf
507,https://www.ema.europa.eu/en/documents/product-information/zinforo-epar-product-information_en.pdf
508,https://www.ema.europa.eu/en/documents/product-information/sugammadex-fresenius-kabi-epar-product-information_en.pdf
509,https://www.ema.europa.eu/en/documents/product-information/aybintio-epar-product-information_en.pdf
510,https://www.ema.europa.eu/en/documents/product-information/sitagliptin-accord-epar-product-information_en.pdf
511,https://www.ema.europa.eu/en/documents/product-information/onbevzi-epar-product-information_en.pdf
512,https://www.ema.europa.eu/en/documents/product-information/mylotarg-epar-product-information_en.pdf
513,https://www.ema.europa.eu/en/documents/product-information/xgeva-epar-product-information_en.pdf
514,https://www.ema.europa.eu/en/documents/product-information/kapruvia-epar-product-information_en.pdf
515,https://www.ema.europa.eu/en/documents/product-information/otezla-epar-product-information_en.pdf
516,https://www.ema.europa.eu/en/documents/product-information/dimethyl-fumarate-neuraxpharm-epar-product-information_en.pdf
517,https://www.ema.europa.eu/en/documents/product-information/cimzia-epar-product-information_en.pdf
518,https://www.ema.europa.eu/en/documents/product-information/ganfort-epar-product-information_en.pdf
519,https://www.ema.europa.eu/en/documents/product-information/ozurdex-epar-product-information_en.pdf
520,https://www.ema.europa.eu/en/documents/product-information/biktarvy-epar-product-information_en.pdf
521,https://www.ema.europa.eu/en/documents/product-information/lumigan-epar-product-information_en.pdf
522,https://www.ema.europa.eu/en/documents/product-information/kineret-epar-product-information_en.pdf
523,https://www.ema.europa.eu/en/documents/product-information/ganirelix-gedeon-richter-epar-product-information_en.pdf
524,https://www.ema.europa.eu/en/documents/product-information/stivarga-epar-product-information_en.pdf
525,https://www.ema.europa.eu/en/documents/product-information/roclanda-epar-product-information_en.pdf
526,https://www.ema.europa.eu/en/documents/product-information/zeffix-epar-product-information_en.pdf
527,https://www.ema.europa.eu/en/documents/product-information/azacitidine-accord-epar-product-information_en.pdf
528,https://www.ema.europa.eu/en/documents/product-information/oncaspar-epar-product-information_en.pdf
529,https://www.ema.europa.eu/en/documents/product-information/potactasol-epar-product-information_en.pdf
530,https://www.ema.europa.eu/en/documents/product-information/filgrastim-hexal-epar-product-information_en.pdf
531,https://www.ema.europa.eu/en/documents/product-information/zarzio-epar-product-information_en.pdf
532,https://www.ema.europa.eu/en/documents/product-information/elmiron-epar-product-information_en.pdf
533,https://www.ema.europa.eu/en/documents/product-information/zaltrap-epar-product-information_en.pdf
534,https://www.ema.europa.eu/en/documents/product-information/zonisamide-mylan-epar-product-information_en.pdf
535,https://www.ema.europa.eu/en/documents/product-information/synagis-epar-product-information_en.pdf
536,
537,https://www.ema.europa.eu/en/documents/product-information/dexdor-epar-product-information_en.pdf
538,https://www.ema.europa.eu/en/documents/product-information/bevespi-aerosphere-epar-product-information_en.pdf
539,https://www.ema.europa.eu/documents/product-information/copiktra-epar-product-information_en.pdf
540,https://www.ema.europa.eu/en/documents/product-information/evoltra-epar-product-information_en.pdf
541,https://www.ema.europa.eu/en/documents/product-information/aripiprazole-accord-epar-product-information_en.pdf
542,https://www.ema.europa.eu/en/documents/product-information/veyvondi-epar-product-information_en.pdf
543,https://www.ema.europa.eu/en/documents/product-information/jalra-epar-product-information_en.pdf
544,https://www.ema.europa.eu/en/documents/product-information/ceprotin-epar-product-information_en.pdf
545,https://www.ema.europa.eu/en/documents/product-information/yescarta-epar-product-information_en.pdf
546,https://www.ema.europa.eu/documents/product-information/trodelvy-epar-product-information_en.pdf
547,https://www.ema.europa.eu/en/documents/product-information/darzalex-epar-product-information_en.pdf
548,https://www.ema.europa.eu/en/documents/product-information/azopt-epar-product-information_en.pdf
549,https://www.ema.europa.eu/en/documents/product-information/naglazyme-epar-product-information_en.pdf
550,https://www.ema.europa.eu/en/documents/product-information/dovprela-epar-product-information_en.pdf
551,https://www.ema.europa.eu/en/documents/product-information/clopidogrel-tad-epar-product-information_en.pdf
552,https://www.ema.europa.eu/en/documents/product-information/xofigo-epar-product-information_en.pdf
553,https://www.ema.europa.eu/en/documents/product-information/nemdatine-epar-product-information_en.pdf
554,https://www.ema.europa.eu/en/documents/product-information/zepatier-epar-product-information_en.pdf
555,https://www.ema.europa.eu/en/documents/product-information/evenity-epar-product-information_en.pdf
556,
557,https://www.ema.europa.eu/en/documents/product-information/epclusa-epar-product-information_en.pdf
558,https://www.ema.europa.eu/en/documents/product-information/levetiracetam-teva-epar-product-information_en.pdf
559,https://www.ema.europa.eu/en/documents/product-information/ibandronic-acid-sandoz-epar-product-information_en.pdf
560,https://www.ema.europa.eu/en/documents/product-information/dificlir-epar-product-information_en.pdf
561,https://www.ema.europa.eu/en/documents/product-information/alymsys-epar-product-information_en.pdf
562,https://www.ema.europa.eu/en/documents/product-information/ucedane-epar-product-information_en.pdf
563,https://www.ema.europa.eu/en/documents/product-information/vectibix-epar-product-information_en.pdf
564,https://www.ema.europa.eu/en/documents/product-information/iressa-epar-product-information_en.pdf
565,https://www.ema.europa.eu/en/documents/product-information/nerlynx-epar-product-information_en.pdf
566,https://www.ema.europa.eu/en/documents/product-information/zavicefta-epar-product-information_en.pdf
567,https://www.ema.europa.eu/en/documents/product-information/elonva-epar-product-information_en.pdf
568,https://www.ema.europa.eu/en/documents/product-information/oyavas-epar-product-information_en.pdf
569,https://www.ema.europa.eu/en/documents/product-information/senshio-epar-product-information_en.pdf
570,https://www.ema.europa.eu/en/documents/product-information/advate-epar-product-information_en.pdf
571,https://www.ema.europa.eu/en/documents/product-information/mysimba-epar-product-information_en.pdf
572,
573,https://www.ema.europa.eu/en/documents/product-information/vizarsin-epar-product-information_en.pdf
574,https://www.ema.europa.eu/en/documents/product-information/mysildecard-epar-product-information_en.pdf
575,https://www.ema.europa.eu/en/documents/product-information/benlysta-epar-product-information_en.pdf
576,https://www.ema.europa.eu/en/documents/product-information/sildenafil-teva-epar-product-information_en.pdf
577,
578,https://www.ema.europa.eu/en/documents/product-information/uptravi-epar-product-information_en.pdf
579,https://www.ema.europa.eu/en/documents/product-information/avastin-epar-product-information_en.pdf
580,https://www.ema.europa.eu/en/documents/product-information/pregabalin-sandoz-epar-product-information_en.pdf
581,https://www.ema.europa.eu/en/documents/product-information/cuprymina-epar-product-information_en.pdf
582,https://www.ema.europa.eu/en/documents/product-information/levetiracetam-actavis-epar-product-information_en.pdf
583,https://www.ema.europa.eu/en/documents/product-information/pregabalin-sandoz-gmbh-epar-product-information_en.pdf
584,https://www.ema.europa.eu/en/documents/product-information/zostavax-epar-product-information_en.pdf
585,https://www.ema.europa.eu/en/documents/product-information/ristfor-epar-product-information_en.pdf
586,https://www.ema.europa.eu/en/documents/product-information/clopidogrel-taw-pharma-previously-clopidogrel-mylan-epar-product-information_en.pdf
587,
588,https://www.ema.europa.eu/en/documents/product-information/levetiracetam-actavis-group-epar-product-information_en.pdf
589,https://www.ema.europa.eu/en/documents/product-information/ristaben-epar-product-information_en.pdf
590,https://www.ema.europa.eu/en/documents/product-information/samsca-epar-product-information_en.pdf
591,https://www.ema.europa.eu/en/documents/product-information/caprelsa-epar-product-information_en.pdf
592,https://www.ema.europa.eu/en/documents/product-information/januvia-epar-product-information_en.pdf
593,https://www.ema.europa.eu/en/documents/product-information/abiraterone-mylan-epar-product-information_en.pdf
594,https://www.ema.europa.eu/en/documents/product-information/rapiscan-epar-product-information_en.pdf
595,https://www.ema.europa.eu/en/documents/product-information/tadalafil-mylan-epar-product-information_en.pdf
596,https://www.ema.europa.eu/en/documents/product-information/tesavel-epar-product-information_en.pdf
597,https://www.ema.europa.eu/en/documents/product-information/hyqvia-epar-product-information_en.pdf
598,https://www.ema.europa.eu/en/documents/product-information/memantine-ratiopharm-epar-product-information_en.pdf
599,https://www.ema.europa.eu/en/documents/product-information/ocaliva-epar-product-information_en.pdf
600,https://www.ema.europa.eu/en/documents/product-information/saxenda-epar-product-information_en.pdf
601,https://www.ema.europa.eu/en/documents/product-information/rotarix-epar-product-information_en.pdf
602,https://www.ema.europa.eu/en/documents/product-information/luminity-epar-product-information_en.pdf
603,https://www.ema.europa.eu/en/documents/product-information/olumiant-epar-product-information_en.pdf
604,https://www.ema.europa.eu/en/documents/product-information/ambrisentan-mylan-epar-product-information_en.pdf
605,https://www.ema.europa.eu/en/documents/product-information/opsumit-epar-product-information_en.pdf
606,https://www.ema.europa.eu/en/documents/product-information/bemfola-epar-product-information_en.pdf
607,https://www.ema.europa.eu/en/documents/product-information/prasugrel-mylan-epar-product-information_en.pdf
608,https://www.ema.europa.eu/en/documents/product-information/sildenafil-actavis-epar-product-information_en.pdf
609,https://www.ema.europa.eu/en/documents/product-information/bronchitol-epar-product-information_en.pdf
610,https://www.ema.europa.eu/en/documents/product-information/optison-epar-product-information_en.pdf
611,https://www.ema.europa.eu/en/documents/product-information/rozlytrek-epar-product-information_en.pdf
612,https://www.ema.europa.eu/en/documents/product-information/edistride-epar-product-information_en-0.pdf
613,https://www.ema.europa.eu/en/documents/product-information/kiovig-epar-product-information_en.pdf
614,https://www.ema.europa.eu/en/documents/product-information/votubia-epar-product-information_en.pdf
615,https://www.ema.europa.eu/en/documents/product-information/afinitor-epar-product-information_en.pdf
616,https://www.ema.europa.eu/en/documents/product-information/xalkori-epar-product-information_en.pdf
617,
618,https://www.ema.europa.eu/en/documents/product-information/azacitidine-mylan-epar-product-information_en.pdf
619,https://www.ema.europa.eu/en/documents/product-information/levetiracetam-sun-epar-product-information_en.pdf
620,https://www.ema.europa.eu/en/documents/product-information/accofil-epar-product-information_en.pdf
621,
622,https://www.ema.europa.eu/en/documents/product-information/desloratadine-ratiopharm-epar-product-information_en.pdf
623,
624,https://www.ema.europa.eu/en/documents/product-information/sildenafil-ratiopharm-epar-product-information_en.pdf
625,https://www.ema.europa.eu/documents/product-information/efmody-epar-product-information_en.pdf
626,https://www.ema.europa.eu/en/documents/product-information/imatinib-accord-epar-product-information_en.pdf
627,https://www.ema.europa.eu/en/documents/product-information/lysakare-epar-product-information_en.pdf
628,https://www.ema.europa.eu/en/documents/product-information/clopidogrel-zentiva-epar-product-information_en.pdf
629,https://www.ema.europa.eu/en/documents/product-information/myfenax-epar-product-information_en.pdf
630,https://www.ema.europa.eu/en/documents/product-information/lunsumio-epar-product-information_en.pdf
631,https://www.ema.europa.eu/en/documents/product-information/erivedge-epar-product-information_en.pdf
632,https://www.ema.europa.eu/en/documents/product-information/givlaari-epar-product-information_en.pdf
633,
634,https://www.ema.europa.eu/en/documents/product-information/kanuma-epar-product-information_en.pdf
635,https://www.ema.europa.eu/en/documents/product-information/adcetris-epar-product-information_en.pdf
636,https://www.ema.europa.eu/en/documents/product-information/torisel-epar-product-information_en.pdf
637,
638,
639,https://www.ema.europa.eu/en/documents/product-information/carvykti-epar-product-information_en.pdf
640,https://www.ema.europa.eu/en/documents/product-information/dimethyl-fumarate-polpharma-epar-product-information_en.pdf
641,https://www.ema.europa.eu/en/documents/product-information/ondexxya-epar-product-information_en.pdf
642,https://www.ema.europa.eu/en/documents/product-information/gefitinib-mylan-epar-product-information_en.pdf
643,https://www.ema.europa.eu/en/documents/product-information/kisplyx-epar-product-information_en.pdf
644,https://www.ema.europa.eu/en/documents/product-information/evrysdi-epar-product-information_en.pdf
645,https://www.ema.europa.eu/en/documents/product-information/sprycel-epar-product-information_en.pdf
646,https://www.ema.europa.eu/en/documents/product-information/xtandi-epar-product-information_en.pdf
647,https://www.ema.europa.eu/en/documents/product-information/ninlaro-epar-product-information_en.pdf
648,https://www.ema.europa.eu/en/documents/product-information/zynrelef-epar-product-information_en.pdf
649,https://www.ema.europa.eu/en/documents/product-information/sondelbay-epar-product-information_en.pdf
650,https://www.ema.europa.eu/en/documents/product-information/enbrel-epar-product-information_en.pdf
651,https://www.ema.europa.eu/en/documents/product-information/fabrazyme-epar-product-information_en.pdf
652,https://www.ema.europa.eu/en/documents/product-information/kyprolis-epar-product-information_en.pdf
653,
654,https://www.ema.europa.eu/en/documents/product-information/pemazyre-epar-product-information_en.pdf
655,https://www.ema.europa.eu/en/documents/product-information/levetiracetam-hospira-epar-product-information_en.pdf
656,https://www.ema.europa.eu/documents/product-information/truvelog-mix-30-epar-product-information_en.pdf
657,https://www.ema.europa.eu/en/documents/product-information/adempas-epar-product-information_en.pdf
658,https://www.ema.europa.eu/en/documents/product-information/vidaza-epar-product-information_en.pdf
659,https://www.ema.europa.eu/en/documents/product-information/cotellic-epar-product-information_en.pdf
660,https://www.ema.europa.eu/en/documents/product-information/minjuvi-epar-product-information_en.pdf
661,https://www.ema.europa.eu/en/documents/product-information/dasatinib-accord-epar-product-information_en.pdf
662,
663,
664,https://www.ema.europa.eu/en/documents/product-information/levetiracetam-ratiopharm-epar-product-information_en.pdf
665,https://www.ema.europa.eu/en/documents/product-information/zyllt-epar-product-information_en.pdf
666,
667,https://www.ema.europa.eu/en/documents/product-information/clopidogrel-krka-epar-product-information_en.pdf
668,https://www.ema.europa.eu/en/documents/product-information/nuceiva-epar-product-information_en.pdf
669,https://www.ema.europa.eu/en/documents/product-information/palynziq-epar-product-information_en.pdf
670,https://www.ema.europa.eu/en/documents/product-information/gavreto-epar-product-information_en.pdf
671,https://www.ema.europa.eu/en/documents/product-information/imatinib-teva-epar-product-information_en.pdf
672,https://www.ema.europa.eu/en/documents/product-information/matever-epar-product-information_en.pdf
673,https://www.ema.europa.eu/en/documents/product-information/talmanco-epar-product-information_en.pdf
674,https://www.ema.europa.eu/en/documents/product-information/desloratadine-teva-epar-product-information_en.pdf
675,https://www.ema.europa.eu/en/documents/product-information/desloratadine-actavis-epar-product-information_en.pdf
676,https://www.ema.europa.eu/en/documents/product-information/dasselta-epar-product-information_en.pdf
677,https://www.ema.europa.eu/en/documents/product-information/qtern-epar-product-information_en.pdf
678,https://www.ema.europa.eu/en/documents/product-information/aerinaze-epar-product-information_en.pdf
679,
680,https://www.ema.europa.eu/en/documents/product-information/bosulif-epar-product-information_en.pdf
681,https://www.ema.europa.eu/en/documents/product-information/roteas-epar-product-information_en.pdf
682,https://www.ema.europa.eu/en/documents/product-information/lixiana-epar-product-information_en.pdf
683,https://www.ema.europa.eu/en/documents/product-information/flixabi-epar-product-information_en.pdf
684,https://www.ema.europa.eu/en/documents/product-information/deferiprone-lipomed-epar-product-information_en.pdf
685,https://www.ema.europa.eu/en/documents/product-information/xromi-epar-product-information_en.pdf
686,
687,https://www.ema.europa.eu/en/documents/product-information/travatan-epar-product-information_en.pdf
688,https://www.ema.europa.eu/en/documents/product-information/evista-epar-product-information_en.pdf
689,https://www.ema.europa.eu/en/documents/product-information/reagila-epar-product-information_en.pdf
690,https://www.ema.europa.eu/en/documents/product-information/symkevi-epar-product-information_en.pdf
691,https://www.ema.europa.eu/en/documents/product-information/ajovy-epar-product-information_en.pdf
692,
693,https://www.ema.europa.eu/documents/product-information/ponvory-epar-product-information_en.pdf
694,https://www.ema.europa.eu/en/documents/product-information/efficib-epar-product-information_en.pdf
695,https://www.ema.europa.eu/en/documents/product-information/janumet-epar-product-information_en.pdf
696,https://www.ema.europa.eu/en/documents/product-information/temozolomide-hexal-epar-product-information_en.pdf
697,https://www.ema.europa.eu/en/documents/product-information/temozolomide-sandoz-epar-product-information_en.pdf
698,https://www.ema.europa.eu/en/documents/product-information/glyxambi-epar-product-information_en.pdf
699,https://www.ema.europa.eu/en/documents/product-information/synjardy-epar-product-information_en.pdf
700,https://www.ema.europa.eu/en/documents/product-information/lysodren-epar-product-information_en.pdf
701,https://www.ema.europa.eu/en/documents/product-information/erbitux-epar-product-information_en.pdf
702,https://www.ema.europa.eu/en/documents/product-information/nimenrix-epar-product-information_en.pdf
703,https://www.ema.europa.eu/en/documents/product-information/firdapse-epar-product-information_en.pdf
704,https://www.ema.europa.eu/en/documents/product-information/velphoro-epar-product-information_en.pdf
705,https://www.ema.europa.eu/en/documents/product-information/tecfidera-epar-product-information_en.pdf
706,https://www.ema.europa.eu/en/documents/product-information/amifampridine-serb-epar-product-information_en.pdf
707,https://www.ema.europa.eu/en/documents/product-information/actos-epar-product-information_en.pdf
708,
709,
710,
711,https://www.ema.europa.eu/en/documents/product-information/pantozol-control-epar-product-information_en.pdf
712,https://www.ema.europa.eu/en/documents/product-information/somac-control-epar-product-information_en.pdf
713,https://www.ema.europa.eu/en/documents/product-information/controloc-control-epar-product-information_en.pdf
714,https://www.ema.europa.eu/en/documents/product-information/xolair-epar-product-information_en.pdf
715,https://www.ema.europa.eu/en/documents/product-information/zessly-epar-product-information_en.pdf
716,https://www.ema.europa.eu/en/documents/product-information/riltrava-aerosphere-epar-product-information_en.pdf
717,https://www.ema.europa.eu/en/documents/product-information/trixeo-aerosphere-epar-product-information_en.pdf
718,https://www.ema.europa.eu/en/documents/product-information/breyanzi-epar-product-information_en.pdf
719,https://www.ema.europa.eu/en/documents/product-information/xospata-epar-product-information_en.pdf
720,https://www.ema.europa.eu/en/documents/product-information/menquadfi-epar-product-information_en.pdf
721,https://www.ema.europa.eu/en/documents/product-information/apixaban-accord-epar-product-information_en.pdf
722,https://www.ema.europa.eu/en/documents/product-information/prehevbri-epar-product-information_en.pdf
723,https://www.ema.europa.eu/en/documents/product-information/ayvakyt-epar-product-information_en.pdf
724,https://www.ema.europa.eu/en/documents/product-information/padcev-epar-product-information_en.pdf
725,https://www.ema.europa.eu/documents/product-information/alunbrig-epar-product-information_en.pdf
726,
727,https://www.ema.europa.eu/en/documents/product-information/selincro-epar-product-information_en.pdf
728,https://www.ema.europa.eu/en/documents/product-information/bimzelx-epar-product-information_en.pdf
729,
730,https://www.ema.europa.eu/en/documents/product-information/deferasirox-mylan-epar-product-information_en.pdf
731,https://www.ema.europa.eu/en/documents/product-information/leflunomide-ratiopharm-epar-product-information_en.pdf
732,https://www.ema.europa.eu/en/documents/product-information/leflunomide-medac-epar-product-information_en.pdf
733,
734,
735,https://www.ema.europa.eu/en/documents/product-information/arsenic-trioxide-mylan-epar-product-information_en.pdf
736,https://www.ema.europa.eu/en/documents/product-information/ongentys-epar-product-information_en.pdf
737,https://www.ema.europa.eu/en/documents/product-information/voncento-epar-product-information_en.pdf
738,https://www.ema.europa.eu/en/documents/product-information/abraxane-epar-product-information_en.pdf
739,https://www.ema.europa.eu/en/documents/product-information/zytiga-epar-product-information_en.pdf
740,https://www.ema.europa.eu/en/documents/product-information/axumin-epar-product-information_en.pdf
741,https://www.ema.europa.eu/en/documents/product-information/ozawade-epar-product-information_en.pdf
742,https://www.ema.europa.eu/en/documents/product-information/arsenic-trioxide-accord-epar-product-information_en.pdf
743,https://www.ema.europa.eu/en/documents/product-information/inflectra-epar-product-information_en.pdf
744,https://www.ema.europa.eu/en/documents/product-information/galafold-epar-product-information_en.pdf
745,https://www.ema.europa.eu/en/documents/product-information/taltz-epar-product-information_en.pdf
746,https://www.ema.europa.eu/en/documents/product-information/kevzara-epar-product-information_en.pdf
747,https://www.ema.europa.eu/en/documents/product-information/infanrix-hexa-epar-product-information_en.pdf
748,https://www.ema.europa.eu/en/documents/product-information/kyntheum-epar-product-information_en.pdf
749,https://www.ema.europa.eu/en/documents/product-information/fampridine-accord-epar-product-information_en.pdf
750,https://www.ema.europa.eu/en/documents/product-information/rivastigmine-actavis-epar-product-information_en.pdf
751,https://www.ema.europa.eu/en/documents/product-information/mavenclad-epar-product-information_en.pdf
752,https://www.ema.europa.eu/en/documents/product-information/gazyvaro-epar-product-information_en.pdf
753,https://www.ema.europa.eu/en/documents/product-information/vfend-epar-product-information_en.pdf
754,https://www.ema.europa.eu/documents/product-information/tepmetko-epar-product-information_en.pdf
755,https://www.ema.europa.eu/en/documents/product-information/pregabalin-zentiva-ks-epar-product-information_en.pdf
756,https://www.ema.europa.eu/en/documents/product-information/fampyra-epar-product-information_en.pdf
757,https://www.ema.europa.eu/en/documents/product-information/cervarix-epar-product-information_en.pdf
758,
759,https://www.ema.europa.eu/en/documents/product-information/pregabalin-zentiva-epar-product-information_en.pdf
760,https://www.ema.europa.eu/documents/product-information/brukinsa-epar-product-information_en.pdf
761,https://www.ema.europa.eu/en/documents/product-information/alimta-epar-product-information_en.pdf
762,https://www.ema.europa.eu/en/documents/product-information/ultomiris-epar-product-information_en.pdf
763,https://www.ema.europa.eu/documents/product-information/lydisilka-epar-product-information_en.pdf
764,https://www.ema.europa.eu/documents/product-information/drovelis-epar-product-information_en.pdf
765,https://www.ema.europa.eu/documents/product-information/poteligeo-epar-product-information_en.pdf
766,https://www.ema.europa.eu/en/documents/product-information/brilique-epar-product-information_en.pdf
767,https://www.ema.europa.eu/en/documents/product-information/sibnayal-epar-product-information_en.pdf
768,
769,https://www.ema.europa.eu/en/documents/product-information/arsenic-trioxide-medac-epar-product-information_en.pdf
770,https://www.ema.europa.eu/en/documents/product-information/ofev-epar-product-information_en.pdf
771,https://www.ema.europa.eu/en/documents/product-information/voriconazole-accord-epar-product-information_en.pdf
772,
773,
774,https://www.ema.europa.eu/en/documents/product-information/simbrinza-epar-product-information_en.pdf
775,https://www.ema.europa.eu/en/documents/product-information/zinplava-epar-product-information_en.pdf
776,https://www.ema.europa.eu/en/documents/product-information/duloxetine-mylan-epar-product-information_en.pdf
777,https://www.ema.europa.eu/documents/product-information/kimmtrak-epar-product-information_en.pdf
778,https://www.ema.europa.eu/en/documents/product-information/nutropinaq-epar-product-information_en.pdf
779,https://www.ema.europa.eu/en/documents/product-information/nustendi-epar-product-information_en.pdf
780,https://www.ema.europa.eu/en/documents/product-information/imlygic-epar-product-information_en.pdf
781,https://www.ema.europa.eu/en/documents/product-information/pregabalin-accord-epar-product-information_en.pdf
782,https://www.ema.europa.eu/documents/product-information/verzenios-epar-product-information_en.pdf
783,https://www.ema.europa.eu/en/documents/product-information/nubeqa-epar-product-information_en.pdf
784,https://www.ema.europa.eu/en/documents/product-information/memantine-merz-epar-product-information_en.pdf
785,https://www.ema.europa.eu/en/documents/product-information/nulojix-epar-product-information_en.pdf
786,https://www.ema.europa.eu/en/documents/product-information/oxbryta-epar-product-information_en.pdf
787,https://www.ema.europa.eu/en/documents/product-information/eptifibatide-accord-epar-product-information_en.pdf
788,https://www.ema.europa.eu/en/documents/product-information/dexmedetomidine-accord-epar-product-information_en.pdf
789,
790,https://www.ema.europa.eu/en/documents/product-information/byooviz-epar-product-information_en.pdf
791,https://www.ema.europa.eu/en/documents/product-information/toujeo-epar-product-information_en.pdf
792,https://www.ema.europa.eu/en/documents/product-information/multaq-epar-product-information_en.pdf
793,https://www.ema.europa.eu/en/documents/product-information/abilify-epar-product-information_en.pdf
794,https://www.ema.europa.eu/en/documents/product-information/cabazitaxel-accord-epar-product-information_en.pdf
795,https://www.ema.europa.eu/en/documents/product-information/nilemdo-epar-product-information_en.pdf
796,https://www.ema.europa.eu/en/documents/product-information/insulin-lispro-sanofi-epar-product-information_en.pdf
797,https://www.ema.europa.eu/en/documents/product-information/febuxostat-krka-epar-product-information_en.pdf
798,https://www.ema.europa.eu/en/documents/product-information/abecma-epar-product-information_en.pdf
799,https://www.ema.europa.eu/en/documents/product-information/daptomycin-hospira-epar-product-information_en.pdf
800,https://www.ema.europa.eu/en/documents/product-information/dukoral-epar-product-information_en.pdf
801,https://www.ema.europa.eu/en/documents/product-information/nimvastid-epar-product-information_en.pdf
802,https://www.ema.europa.eu/en/documents/product-information/foclivia-epar-product-information_en.pdf
803,https://www.ema.europa.eu/en/documents/product-information/emadine-epar-product-information_en.pdf
804,https://www.ema.europa.eu/en/documents/product-information/urorec-epar-product-information_en.pdf
805,https://www.ema.europa.eu/en/documents/product-information/tresiba-epar-product-information_en.pdf
806,https://www.ema.europa.eu/en/documents/product-information/glivec-epar-product-information_en.pdf
807,https://www.ema.europa.eu/en/documents/product-information/farydak-epar-product-information_en.pdf
808,https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf
809,https://www.ema.europa.eu/en/documents/product-information/oxervate-epar-product-information_en.pdf
810,https://www.ema.europa.eu/en/documents/product-information/stimufend-epar-product-information_en.pdf
811,https://www.ema.europa.eu/en/documents/product-information/trimbow-epar-product-information_en.pdf
812,https://www.ema.europa.eu/en/documents/product-information/lumykras-epar-product-information_en.pdf
813,https://www.ema.europa.eu/en/documents/product-information/lenalidomide-accord-epar-product-information_en.pdf
814,https://www.ema.europa.eu/en/documents/product-information/tractocile-epar-product-information_en.pdf
815,https://www.ema.europa.eu/en/documents/product-information/avamys-epar-product-information_en.pdf
816,https://www.ema.europa.eu/en/documents/product-information/temomedac-epar-product-information_en.pdf
817,https://www.ema.europa.eu/en/documents/product-information/rivaroxaban-accord-epar-product-information_en.pdf
818,https://www.ema.europa.eu/en/documents/product-information/arava-epar-product-information_en.pdf
819,https://www.ema.europa.eu/en/documents/product-information/rekovelle-epar-product-information_en.pdf
820,https://www.ema.europa.eu/en/documents/product-information/bortezomib-accord-epar-product-information_en.pdf
821,https://www.ema.europa.eu/en/documents/product-information/yondelis-epar-product-information_en.pdf
822,
823,https://www.ema.europa.eu/en/documents/product-information/zonegran-epar-product-information_en.pdf
824,
825,https://www.ema.europa.eu/en/documents/product-information/kesimpta-epar-product-information_en.pdf
826,https://www.ema.europa.eu/en/documents/product-information/kerendia-epar-product-information_en.pdf
827,https://www.ema.europa.eu/en/documents/product-information/ameluz-epar-product-information_en.pdf
828,https://www.ema.europa.eu/en/documents/product-information/lojuxta-epar-product-information_en.pdf
829,https://www.ema.europa.eu/en/documents/product-information/viread-epar-product-information_en.pdf
830,https://www.ema.europa.eu/en/documents/product-information/novothirteen-epar-product-information_en.pdf
831,https://www.ema.europa.eu/en/documents/product-information/temozolomide-accord-epar-product-information_en.pdf
832,https://www.ema.europa.eu/en/documents/product-information/ronapreve-epar-product-information_en.pdf
833,https://www.ema.europa.eu/en/documents/product-information/integrilin-epar-product-information_en.pdf
834,https://www.ema.europa.eu/en/documents/product-information/latuda-epar-product-information_en.pdf
835,https://www.ema.europa.eu/en/documents/product-information/temozolomide-sun-epar-product-information_en.pdf
836,https://www.ema.europa.eu/en/documents/product-information/liprolog-epar-product-information_en.pdf
837,https://www.ema.europa.eu/en/documents/product-information/besponsa-epar-product-information_en.pdf
838,https://www.ema.europa.eu/en/documents/product-information/sivextro-epar-product-information_en.pdf
839,https://www.ema.europa.eu/en/documents/product-information/tyverb-epar-product-information_en.pdf
840,https://www.ema.europa.eu/en/documents/product-information/mirvaso-epar-product-information_en.pdf
841,https://www.ema.europa.eu/en/documents/product-information/pazenir-epar-product-information_en.pdf
842,https://www.ema.europa.eu/en/documents/product-information/zebinix-epar-product-information_en.pdf
843,https://www.ema.europa.eu/en/documents/product-information/adynovi-epar-product-information_en.pdf
844,https://www.ema.europa.eu/en/documents/product-information/kentera-epar-product-information_en.pdf
845,https://www.ema.europa.eu/en/documents/product-information/hyrimoz-epar-product-information_en.pdf
846,https://www.ema.europa.eu/documents/product-information/fingolimod-accord-epar-product-information_en.pdf
847,https://www.ema.europa.eu/en/documents/product-information/hefiya-epar-product-information_en.pdf
848,https://www.ema.europa.eu/en/documents/product-information/trisenox-epar-product-information_en.pdf
849,https://www.ema.europa.eu/en/documents/product-information/keppra-epar-product-information_en.pdf
850,https://www.ema.europa.eu/en/documents/product-information/trydonis-epar-product-information_en.pdf
851,https://www.ema.europa.eu/en/documents/product-information/refixia-epar-product-information_en.pdf
852,https://www.ema.europa.eu/en/documents/product-information/jentadueto-epar-product-information_en.pdf
853,https://www.ema.europa.eu/en/documents/product-information/vokanamet-epar-product-information_en.pdf
854,https://www.ema.europa.eu/en/documents/product-information/invokana-epar-product-information_en.pdf
855,https://www.ema.europa.eu/en/documents/product-information/alofisel-epar-product-information_en.pdf
856,https://www.ema.europa.eu/documents/product-information/jayempi-epar-product-information_en.pdf
857,https://www.ema.europa.eu/en/documents/product-information/brinavess-epar-product-information_en.pdf
858,https://www.ema.europa.eu/en/documents/product-information/cellcept-epar-product-information_en.pdf
859,https://www.ema.europa.eu/en/documents/product-information/yargesa-epar-product-information_en.pdf
860,https://www.ema.europa.eu/en/documents/product-information/phesgo-epar-product-information_en.pdf
861,https://www.ema.europa.eu/en/documents/product-information/zavesca-epar-product-information_en.pdf
862,https://www.ema.europa.eu/en/documents/product-information/aimovig-epar-product-information_en.pdf
863,https://www.ema.europa.eu/en/documents/product-information/ivabradine-accord-epar-product-information_en.pdf
864,https://www.ema.europa.eu/en/documents/product-information/bortezomib-hospira-epar-product-information_en.pdf
865,https://www.ema.europa.eu/en/documents/product-information/tandemact-epar-product-information_en.pdf
866,https://www.ema.europa.eu/en/documents/product-information/jylamvo-epar-product-information_en.pdf
867,https://www.ema.europa.eu/en/documents/product-information/tolucombi-epar-product-information_en.pdf
868,https://www.ema.europa.eu/en/documents/product-information/zykadia-epar-product-information_en.pdf
869,https://www.ema.europa.eu/en/documents/product-information/rivaroxaban-mylan-epar-product-information_en.pdf
870,https://www.ema.europa.eu/en/documents/product-information/voxzogo-epar-product-information_en.pdf
871,https://www.ema.europa.eu/en/documents/product-information/feraccru-epar-product-information_en.pdf
872,https://www.ema.europa.eu/en/documents/product-information/inpremzia-epar-product-information_en.pdf
873,https://www.ema.europa.eu/en/documents/product-information/noxafil-epar-product-information_en.pdf
874,https://www.ema.europa.eu/en/documents/product-information/gencebok-epar-product-information_en.pdf
875,https://www.ema.europa.eu/en/documents/product-information/oprymea-epar-product-information_en.pdf
876,https://www.ema.europa.eu/en/documents/product-information/suboxone-epar-product-information_en.pdf
877,https://www.ema.europa.eu/en/documents/product-information/orencia-epar-product-information_en.pdf
878,https://www.ema.europa.eu/en/documents/product-information/evotaz-epar-product-information_en.pdf
879,https://www.ema.europa.eu/en/documents/product-information/temozolomide-teva-epar-product-information_en.pdf
880,
881,https://www.ema.europa.eu/en/documents/product-information/steglatro-epar-product-information_en.pdf
882,https://www.ema.europa.eu/en/documents/product-information/segluromet-epar-product-information_en.pdf
883,https://www.ema.europa.eu/en/documents/product-information/empliciti-epar-product-information_en.pdf
884,https://www.ema.europa.eu/en/documents/product-information/karvezide-epar-product-information_en.pdf
885,https://www.ema.europa.eu/en/documents/product-information/coaprovel-epar-product-information_en.pdf
886,https://www.ema.europa.eu/en/documents/product-information/bridion-epar-product-information_en.pdf
887,https://www.ema.europa.eu/en/documents/product-information/zyprexa-velotab-epar-product-information_en.pdf
888,https://www.ema.europa.eu/en/documents/product-information/zypadhera-epar-product-information_en.pdf
889,https://www.ema.europa.eu/en/documents/product-information/alkindi-epar-product-information_en.pdf
890,https://www.ema.europa.eu/en/documents/product-information/baraclude-epar-product-information_en.pdf
891,https://www.ema.europa.eu/en/documents/product-information/translarna-epar-product-information_en.pdf
892,https://www.ema.europa.eu/en/documents/product-information/efavirenz-teva-epar-product-information_en.pdf
893,https://www.ema.europa.eu/en/documents/product-information/datscan-epar-product-information_en.pdf
894,
895,https://www.ema.europa.eu/en/documents/product-information/atosiban-sun-epar-product-information_en.pdf
896,https://www.ema.europa.eu/en/documents/product-information/ifirmacombi-epar-product-information_en.pdf
897,https://www.ema.europa.eu/en/documents/product-information/rasilez-epar-product-information_en.pdf
898,https://www.ema.europa.eu/en/documents/product-information/javlor-epar-product-information_en.pdf
899,https://www.ema.europa.eu/en/documents/product-information/emselex-epar-product-information_en.pdf
900,https://www.ema.europa.eu/en/documents/product-information/busilvex-epar-product-information_en.pdf
901,https://www.ema.europa.eu/en/documents/product-information/deferasirox-accord-epar-product-information_en.pdf
902,
903,
904,https://www.ema.europa.eu/en/documents/product-information/stalevo-epar-product-information_en.pdf
905,https://www.ema.europa.eu/en/documents/product-information/flebogamma-dif-epar-product-information_en.pdf
906,https://www.ema.europa.eu/en/documents/product-information/spinraza-epar-product-information_en.pdf
907,https://www.ema.europa.eu/en/documents/product-information/simponi-epar-product-information_en.pdf
908,https://www.ema.europa.eu/en/documents/product-information/tecovirimat-siga-epar-product-information_en.pdf
909,https://www.ema.europa.eu/en/documents/product-information/ikervis-epar-product-information_en.pdf
910,https://www.ema.europa.eu/en/documents/product-information/xigduo-epar-product-information_en.pdf
911,https://www.ema.europa.eu/en/documents/product-information/ebymect-epar-product-information_en.pdf
912,https://www.ema.europa.eu/en/documents/product-information/insulin-aspart-sanofi-epar-product-information_en.pdf
913,https://www.ema.europa.eu/en/documents/product-information/tavneos-epar-product-information_en.pdf
914,https://www.ema.europa.eu/en/documents/product-information/mektovi-epar-product-information_en.pdf
915,https://www.ema.europa.eu/en/documents/product-information/rapilysin-epar-product-information_en.pdf
916,https://www.ema.europa.eu/documents/product-information/dengvaxia-epar-product-information_en.pdf
917,https://www.ema.europa.eu/en/documents/product-information/cinacalcet-accordpharma-epar-product-information_en.pdf
918,https://www.ema.europa.eu/en/documents/product-information/targretin-epar-product-information_en.pdf
919,https://www.ema.europa.eu/en/documents/product-information/rolufta-ellipta-previously-rolufta-epar-product-information_en.pdf
920,https://www.ema.europa.eu/en/documents/product-information/verkazia-epar-product-information_en.pdf
921,https://www.ema.europa.eu/en/documents/product-information/ledaga-epar-product-information_en.pdf
922,https://www.ema.europa.eu/en/documents/product-information/zoledronic-acid-accord-epar-product-information_en.pdf
923,https://www.ema.europa.eu/en/documents/product-information/repaglinide-accord-epar-product-information_en.pdf
924,https://www.ema.europa.eu/en/documents/product-information/duavive-epar-product-information_en.pdf
925,https://www.ema.europa.eu/en/documents/product-information/kanjinti-epar-product-information_en.pdf
926,https://www.ema.europa.eu/en/documents/product-information/movymia-epar-product-information_en.pdf
927,https://www.ema.europa.eu/en/documents/product-information/neulasta-epar-product-information_en.pdf
928,https://www.ema.europa.eu/en/documents/product-information/forsteo-epar-product-information_en.pdf
929,https://www.ema.europa.eu/en/documents/product-information/plavix-epar-product-information_en.pdf
930,https://www.ema.europa.eu/en/documents/product-information/bemrist-breezhaler-epar-product-information_en.pdf
931,https://www.ema.europa.eu/documents/product-information/voraxaze-epar-product-information_en.pdf
932,https://www.ema.europa.eu/en/documents/product-information/klisyri-epar-product-information_en.pdf
933,https://www.ema.europa.eu/documents/product-information/onpattro-epar-product-information_en.pdf
934,https://www.ema.europa.eu/en/documents/product-information/lamivudine-teva-pharma-bv-epar-product-information_en.pdf
935,https://www.ema.europa.eu/en/documents/product-information/menveo-epar-product-information_en.pdf
936,https://www.ema.europa.eu/en/documents/product-information/tybost-epar-product-information_en.pdf
937,https://www.ema.europa.eu/en/documents/product-information/libmyris-epar-product-information_en.pdf
938,https://www.ema.europa.eu/en/documents/product-information/twinrix-paediatric-epar-product-information_en.pdf
939,https://www.ema.europa.eu/en/documents/product-information/twinrix-adult-epar-product-information_en.pdf
940,https://www.ema.europa.eu/en/documents/product-information/fendrix-epar-product-information_en.pdf
941,https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_en.pdf
942,https://www.ema.europa.eu/en/documents/product-information/azilect-epar-product-information_en.pdf
943,https://www.ema.europa.eu/en/documents/product-information/optruma-epar-product-information_en.pdf
944,https://www.ema.europa.eu/en/documents/product-information/semglee-epar-product-information_en.pdf
945,https://www.ema.europa.eu/en/documents/product-information/hizentra-epar-product-information_en.pdf
946,https://www.ema.europa.eu/en/documents/product-information/quinsair-epar-product-information_en.pdf
947,https://www.ema.europa.eu/en/documents/product-information/lonsurf-epar-product-information_en.pdf
948,https://www.ema.europa.eu/en/documents/product-information/colobreathe-epar-product-information_en.pdf
949,https://www.ema.europa.eu/en/documents/product-information/tolura-epar-product-information_en.pdf
950,https://www.ema.europa.eu/en/documents/product-information/nexium-control-epar-product-information_en.pdf
951,https://www.ema.europa.eu/en/documents/product-information/levetiracetam-accord-epar-product-information_en.pdf
952,https://www.ema.europa.eu/en/documents/product-information/protopic-epar-product-information_en.pdf
953,https://www.ema.europa.eu/en/documents/product-information/pioglitazone-accord-epar-product-information_en.pdf
954,https://www.ema.europa.eu/en/documents/product-information/miglustat-genorph-epar-product-information_en.pdf
955,https://www.ema.europa.eu/documents/product-information/artesunate-amivas-epar-product-information_en.pdf
956,
957,https://www.ema.europa.eu/en/documents/product-information/memantine-accord-epar-product-information_en.pdf
958,https://www.ema.europa.eu/en/documents/product-information/zoely-epar-product-information_en.pdf
959,https://www.ema.europa.eu/en/documents/product-information/increlex-epar-product-information_en.pdf
960,https://www.ema.europa.eu/en/documents/product-information/biopoin-epar-product-information_en.pdf
961,https://www.ema.europa.eu/en/documents/product-information/eporatio-epar-product-information_en.pdf
962,https://www.ema.europa.eu/en/documents/product-information/cerdelga-epar-product-information_en.pdf
963,https://www.ema.europa.eu/en/documents/product-information/beromun-epar-product-information_en.pdf
964,https://www.ema.europa.eu/en/documents/product-information/zyprexa-epar-product-information_en.pdf
965,https://www.ema.europa.eu/en/documents/product-information/grastofil-epar-product-information_en.pdf
966,https://www.ema.europa.eu/en/documents/product-information/twynsta-epar-product-information_en.pdf
967,https://www.ema.europa.eu/en/documents/product-information/mimpara-epar-product-information_en.pdf
968,https://www.ema.europa.eu/documents/product-information/rizmoic-epar-product-information_en.pdf
969,
970,https://www.ema.europa.eu/en/documents/product-information/imnovid-epar-product-information_en.pdf
971,https://www.ema.europa.eu/en/documents/product-information/revlimid-epar-product-information_en.pdf
972,
973,https://www.ema.europa.eu/en/documents/product-information/lamivudine-teva-epar-product-information_en.pdf
974,https://www.ema.europa.eu/en/documents/product-information/holoclar-epar-product-information_en.pdf
975,https://www.ema.europa.eu/en/documents/product-information/mepsevii-epar-product-information_en.pdf
976,
977,https://www.ema.europa.eu/en/documents/product-information/mozobil-epar-product-information_en.pdf
978,
979,https://www.ema.europa.eu/en/documents/product-information/ebixa-epar-product-information_en.pdf
980,https://www.ema.europa.eu/en/documents/product-information/inbrija-epar-product-information_en.pdf
981,https://www.ema.europa.eu/en/documents/product-information/mycamine-epar-product-information_en.pdf
982,https://www.ema.europa.eu/en/documents/product-information/sixmo-epar-product-information_en.pdf
983,https://www.ema.europa.eu/en/documents/product-information/trajenta-epar-product-information_en.pdf
984,https://www.ema.europa.eu/en/documents/product-information/peyona-epar-product-information_en.pdf
985,
986,https://www.ema.europa.eu/en/documents/product-information/docetaxel-accord-epar-product-information_en.pdf
987,
988,https://www.ema.europa.eu/en/documents/product-information/darunavir-krka-epar-product-information_en.pdf
989,https://www.ema.europa.eu/en/documents/product-information/zeposia-epar-product-information_en.pdf
990,https://www.ema.europa.eu/en/documents/product-information/yentreve-epar-product-information_en.pdf
991,https://www.ema.europa.eu/en/documents/product-information/duloxetine-lilly-epar-product-information_en.pdf
992,https://www.ema.europa.eu/en/documents/product-information/cymbalta-epar-product-information_en.pdf
993,https://www.ema.europa.eu/en/documents/product-information/corlentor-epar-product-information_en.pdf
994,https://www.ema.europa.eu/en/documents/product-information/procoralan-epar-product-information_en.pdf
995,https://www.ema.europa.eu/en/documents/product-information/temybric-ellipta-epar-product-information_en.pdf
996,https://www.ema.europa.eu/en/documents/product-information/amgevita-epar-product-information_en.pdf
997,https://www.ema.europa.eu/en/documents/product-information/repaglinide-teva-epar-product-information_en.pdf
998,https://www.ema.europa.eu/en/documents/product-information/lenalidomide-krka-dd-epar-product-information_en.pdf
999,
1000,https://www.ema.europa.eu/en/documents/product-information/seebri-breezhaler-epar-product-information_en.pdf
1001,
1002,https://www.ema.europa.eu/en/documents/product-information/idelvion-epar-product-information_en.pdf
1003,https://www.ema.europa.eu/en/documents/product-information/abilify-maintena-epar-product-information_en.pdf
1004,https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf
1005,https://www.ema.europa.eu/en/documents/product-information/jevtana-epar-product-information_en.pdf
1006,https://www.ema.europa.eu/en/documents/product-information/taxotere-epar-product-information_en.pdf
1007,https://www.ema.europa.eu/documents/product-information/qinlock-epar-product-information_en.pdf
1008,https://www.ema.europa.eu/en/documents/product-information/apidra-epar-product-information_en.pdf
1009,https://www.ema.europa.eu/en/documents/product-information/betaferon-epar-product-information_en.pdf
1010,https://www.ema.europa.eu/en/documents/product-information/rebetol-epar-product-information_en.pdf
1011,https://www.ema.europa.eu/en/documents/product-information/iscover-epar-product-information_en.pdf
1012,https://www.ema.europa.eu/en/documents/product-information/ventavis-epar-product-information_en.pdf
1013,https://www.ema.europa.eu/en/documents/product-information/xarelto-epar-product-information_en.pdf
1014,https://www.ema.europa.eu/en/documents/product-information/aldara-epar-product-information_en.pdf
1015,https://www.ema.europa.eu/en/documents/product-information/pheburane-epar-product-information_en.pdf
1016,https://www.ema.europa.eu/en/documents/product-information/neupro-epar-product-information_en.pdf
1017,https://www.ema.europa.eu/en/documents/product-information/capecitabine-accord-epar-product-information_en.pdf
1018,https://www.ema.europa.eu/en/documents/product-information/tafinlar-epar-product-information_en.pdf
1019,https://www.ema.europa.eu/en/documents/product-information/nevirapine-teva-epar-product-information_en.pdf
1020,https://www.ema.europa.eu/en/documents/product-information/perjeta-epar-product-information_en.pdf
1021,https://www.ema.europa.eu/en/documents/product-information/zalasta-epar-product-information_en.pdf
1022,https://www.ema.europa.eu/en/documents/product-information/atazanavir-krka-epar-product-information_en.pdf
1023,https://www.ema.europa.eu/en/documents/product-information/wakix-epar-product-information_en.pdf
1024,https://www.ema.europa.eu/en/documents/product-information/zimbus-breezhaler-epar-product-information_en.pdf
1025,https://www.ema.europa.eu/en/documents/product-information/zyclara-epar-product-information_en.pdf
1026,https://www.ema.europa.eu/en/documents/product-information/marixino-epar-product-information_en.pdf
1027,https://www.ema.europa.eu/en/documents/product-information/mircera-epar-product-information_en.pdf
1028,https://www.ema.europa.eu/en/documents/product-information/respreeza-epar-product-information_en.pdf
1029,https://www.ema.europa.eu/en/documents/product-information/tevagrastim-epar-product-information_en.pdf
1030,https://www.ema.europa.eu/en/documents/product-information/budesonide/formoterol-teva-pharma-bv-epar-product-information_en.pdf
1031,https://www.ema.europa.eu/en/documents/product-information/repaglinide-krka-epar-product-information_en.pdf
1032,https://www.ema.europa.eu/en/documents/product-information/enyglid-epar-product-information_en.pdf
1033,https://www.ema.europa.eu/en/documents/product-information/calquence-epar-product-information_en.pdf
1034,https://www.ema.europa.eu/en/documents/product-information/inrebic-epar-product-information_en.pdf
1035,https://www.ema.europa.eu/en/documents/product-information/ebilfumin-epar-product-information_en.pdf
1036,https://www.ema.europa.eu/en/documents/product-information/talzenna-epar-product-information_en.pdf
1037,https://www.ema.europa.eu/en/documents/product-information/efient-epar-product-information_en.pdf
1038,https://www.ema.europa.eu/en/documents/product-information/enerzair-breezhaler-epar-product-information_en.pdf
1039,https://www.ema.europa.eu/en/documents/product-information/pixuvri-epar-product-information_en.pdf
1040,https://www.ema.europa.eu/en/documents/product-information/vargatef-epar-product-information_en.pdf
1041,https://www.ema.europa.eu/en/documents/product-information/ratiograstim-epar-product-information_en.pdf
1042,https://www.ema.europa.eu/en/documents/product-information/renagel-epar-product-information_en.pdf
1043,https://www.ema.europa.eu/en/documents/product-information/fareston-epar-product-information_en.pdf
1044,https://www.ema.europa.eu/en/documents/product-information/lantus-epar-product-information_en.pdf
1045,https://www.ema.europa.eu/en/documents/product-information/trevicta-epar-product-information_en.pdf
1046,
1047,https://www.ema.europa.eu/en/documents/product-information/rxulti-epar-product-information_en.pdf
1048,https://www.ema.europa.eu/en/documents/product-information/lenvima-epar-product-information_en.pdf
1049,https://www.ema.europa.eu/en/documents/product-information/retacrit-epar-product-information_en.pdf
1050,https://www.ema.europa.eu/en/documents/product-information/izba-epar-product-information_en.pdf
1051,https://www.ema.europa.eu/en/documents/product-information/steglujan-epar-product-information_en.pdf
1052,https://www.ema.europa.eu/en/documents/product-information/ghryvelin-previously-macimorelin-aeterna-zentaris-epar-product-information_en.pdf
1053,https://www.ema.europa.eu/en/documents/product-information/pioglitazone-teva-epar-product-information_en.pdf
1054,https://www.ema.europa.eu/en/documents/product-information/levitra-epar-product-information_en.pdf
1055,https://www.ema.europa.eu/en/documents/product-information/phelinun-epar-product-information_en.pdf
1056,https://www.ema.europa.eu/en/documents/product-information/neorecormon-epar-product-information_en.pdf
1057,https://www.ema.europa.eu/en/documents/product-information/zelboraf-epar-product-information_en.pdf
1058,https://www.ema.europa.eu/en/documents/overview/ivozall-epar-medicine-overview_en.pdf
1059,https://www.ema.europa.eu/en/documents/product-information/aldurazyme-epar-product-information_en.pdf
1060,https://www.ema.europa.eu/en/documents/product-information/fuzeon-epar-product-information_en.pdf
1061,https://www.ema.europa.eu/en/documents/product-information/thyrogen-epar-product-information_en.pdf
1062,https://www.ema.europa.eu/en/documents/product-information/spedra-epar-product-information_en.pdf
1063,https://www.ema.europa.eu/en/documents/product-information/olanzapine-mylan-epar-product-information_en.pdf
1064,
1065,https://www.ema.europa.eu/en/documents/product-information/pramipexole-teva-epar-product-information_en.pdf
1066,https://www.ema.europa.eu/en/documents/product-information/sirturo-epar-product-information_en.pdf
1067,https://www.ema.europa.eu/en/documents/product-information/rilutek-epar-product-information_en.pdf
1068,https://www.ema.europa.eu/en/documents/product-information/fasturtec-epar-product-information_en.pdf
1069,https://www.ema.europa.eu/en/documents/product-information/kigabeq-epar-product-information_en.pdf
1070,https://www.ema.europa.eu/en/documents/product-information/vantavo-epar-product-information_en.pdf
1071,https://www.ema.europa.eu/en/documents/product-information/puregon-epar-product-information_en.pdf
1072,https://www.ema.europa.eu/en/documents/product-information/cinqaero-epar-product-information_en.pdf
1073,https://www.ema.europa.eu/documents/product-information/silodosin-recordati-epar-product-information_en.pdf
1074,https://www.ema.europa.eu/en/documents/product-information/tadalafil-lilly-epar-product-information_en.pdf
1075,https://www.ema.europa.eu/en/documents/product-information/nevanac-epar-product-information_en.pdf
1076,https://www.ema.europa.eu/en/documents/product-information/jivi-epar-product-information_en.pdf
1077,https://www.ema.europa.eu/en/documents/product-information/fosavance-epar-product-information_en.pdf
1078,https://www.ema.europa.eu/en/documents/product-information/enurev-breezhaler-epar-product-information_en.pdf
1079,https://www.ema.europa.eu/en/documents/product-information/zomarist-epar-product-information_en.pdf
1080,https://www.ema.europa.eu/en/documents/product-information/sycrest-epar-product-information_en.pdf
1081,https://www.ema.europa.eu/en/documents/product-information/orgalutran-epar-product-information_en.pdf
1082,https://www.ema.europa.eu/en/documents/product-information/entacapone-orion-epar-product-information_en.pdf
1083,https://www.ema.europa.eu/en/documents/product-information/zoledronic-acid-hospira-epar-product-information_en.pdf
1084,https://www.ema.europa.eu/en/documents/product-information/tovanor-breezhaler-epar-product-information_en.pdf
1085,https://www.ema.europa.eu/en/documents/product-information/ovitrelle-epar-product-information_en.pdf
1086,https://www.ema.europa.eu/en/documents/product-information/pelmeg-epar-product-information_en.pdf
1087,https://www.ema.europa.eu/en/documents/product-information/arikayce-liposomal-product-information_en.pdf
1088,https://www.ema.europa.eu/en/documents/product-information/votrient-epar-product-information_en.pdf
1089,https://www.ema.europa.eu/en/documents/product-information/comtess-epar-product-information_en.pdf
1090,https://www.ema.europa.eu/en/documents/product-information/betmiga-epar-product-information_en.pdf
1091,https://www.ema.europa.eu/en/documents/product-information/cystagon-epar-product-information_en.pdf
1092,https://www.ema.europa.eu/en/documents/product-information/rasagiline-ratiopharm-epar-product-information_en.pdf
1093,https://www.ema.europa.eu/en/documents/product-information/adrovance-epar-product-information_en.pdf
1094,
1095,https://www.ema.europa.eu/en/documents/product-information/nyvepria-epar-product-information_en.pdf
1096,https://www.ema.europa.eu/en/documents/product-information/recarbrio-epar-product-information_en.pdf
1097,https://www.ema.europa.eu/en/documents/product-information/alprolix-epar-product-information_en.pdf
1098,https://www.ema.europa.eu/en/documents/product-information/terrosa-epar-product-information_en.pdf
1099,
1100,https://www.ema.europa.eu/en/documents/product-information/amsparity-epar-product-information_en.pdf
1101,https://www.ema.europa.eu/en/documents/product-information/tracleer-epar-product-information_en.pdf
1102,https://www.ema.europa.eu/en/documents/product-information/olanzapine-teva-epar-product-information_en.pdf
1103,https://www.ema.europa.eu/en/documents/product-information/vizamyl-epar-product-information_en.pdf
1104,https://www.ema.europa.eu/en/documents/product-information/simulect-epar-product-information_en.pdf
1105,https://www.ema.europa.eu/en/documents/product-information/telmisartan-teva-pharma-epar-product-information_en.pdf
1106,https://www.ema.europa.eu/en/documents/product-information/toviaz-epar-product-information_en.pdf
1107,
1108,https://www.ema.europa.eu/en/documents/product-information/xadago-epar-product-information_en.pdf
1109,https://www.ema.europa.eu/en/documents/product-information/comtan-epar-product-information_en.pdf
1110,https://www.ema.europa.eu/en/documents/product-information/extavia-epar-product-information_en.pdf
1111,https://www.ema.europa.eu/documents/product-information/buvidal-epar-product-information_en.pdf
1112,
1113,https://www.ema.europa.eu/en/documents/product-information/trepulmix-epar-product-information_en.pdf
1114,https://www.ema.europa.eu/en/documents/product-information/omnitrope-epar-product-information_en.pdf
1115,https://www.ema.europa.eu/en/documents/product-information/champix-epar-product-information_en.pdf
1116,https://www.ema.europa.eu/en/documents/product-information/inductos-epar-product-information_en.pdf
1117,https://www.ema.europa.eu/en/documents/product-information/abseamed-epar-product-information_en.pdf
1118,https://www.ema.europa.eu/en/documents/product-information/stribild-epar-product-information_en.pdf
1119,https://www.ema.europa.eu/en/documents/product-information/shingrix-epar-product-information_en.pdf
1120,https://www.ema.europa.eu/en/documents/product-information/besremi-epar-product-information_en.pdf
1121,https://www.ema.europa.eu/en/documents/product-information/qutenza-epar-product-information_en.pdf
1122,https://www.ema.europa.eu/en/documents/product-information/cialis-epar-product-information_en.pdf
1123,
1124,https://www.ema.europa.eu/en/documents/product-information/aclasta-epar-product-information_en.pdf
1125,
1126,https://www.ema.europa.eu/en/documents/product-information/cubicin-epar-product-information_en.pdf
1127,https://www.ema.europa.eu/en/documents/product-information/duotrav-epar-product-information_en.pdf
1128,https://www.ema.europa.eu/en/documents/product-information/dectova-epar-product-information_en.pdf
1129,https://www.ema.europa.eu/en/documents/product-information/zydelig-epar-product-information_en.pdf
1130,https://www.ema.europa.eu/en/documents/product-information/humalog-epar-product-information_en.pdf
1131,https://www.ema.europa.eu/en/documents/product-information/tamiflu-epar-product-information_en.pdf
1132,https://www.ema.europa.eu/en/documents/product-information/riluzole-zentiva-epar-product-information_en.pdf
1133,https://www.ema.europa.eu/documents/product-information/imatinib-koanaa-epar-product-information_en.pdf
1134,https://www.ema.europa.eu/en/documents/product-information/entacapone-teva-epar-product-information_en.pdf
1135,https://www.ema.europa.eu/en/documents/product-information/inlyta-epar-product-information_en.pdf
1136,https://www.ema.europa.eu/en/documents/product-information/volibris-epar-product-information_en.pdf
1137,https://www.ema.europa.eu/en/documents/product-information/raloxifene-teva-epar-product-information_en.pdf
1138,
1139,https://www.ema.europa.eu/en/documents/product-information/fiasp-epar-product-information_en.pdf
1140,https://www.ema.europa.eu/en/documents/product-information/parsabiv-epar-product-information_en.pdf
1141,https://www.ema.europa.eu/en/documents/product-information/cystadane-epar-product-information_en.pdf
1142,https://www.ema.europa.eu/en/documents/product-information/onbrez-breezhaler-epar-product-information_en.pdf
1143,https://www.ema.europa.eu/en/documents/product-information/ryzodeg-epar-product-information_en.pdf
1144,https://www.ema.europa.eu/en/documents/product-information/tachosil-epar-product-information_en.pdf
1145,https://www.ema.europa.eu/en/documents/product-information/cystadrops-epar-product-information_en.pdf
1146,https://www.ema.europa.eu/en/documents/product-information/tenkasi-previously-orbactiv-epar-product-information_en.pdf
1147,https://www.ema.europa.eu/documents/product-information/enspryng-epar-product-information_en.pdf
1148,
1149,https://www.ema.europa.eu/en/documents/product-information/kirsty-previously-kixelle-epar-product-information_en.pdf
1150,https://www.ema.europa.eu/en/documents/product-information/sonovue-epar-product-information_en.pdf
1151,https://www.ema.europa.eu/en/documents/product-information/herceptin-epar-product-information_en.pdf
1152,https://www.ema.europa.eu/en/documents/product-information/bortezomib-sun-epar-product-information_en.pdf
1153,https://www.ema.europa.eu/en/documents/product-information/capecitabine-teva-epar-product-information_en.pdf
1154,https://www.ema.europa.eu/en/documents/product-information/oslif-breezhaler-epar-product-information_en.pdf
1155,https://www.ema.europa.eu/en/documents/product-information/hirobriz-breezhaler-epar-product-information_en.pdf
1156,https://www.ema.europa.eu/en/documents/product-information/xoterna-breezhaler-epar-product-information_en.pdf
1157,https://www.ema.europa.eu/en/documents/product-information/ibandronic-acid-teva-epar-product-information_en.pdf
1158,
1159,https://www.ema.europa.eu/en/documents/product-information/icatibant-accord-epar-product-information_en.pdf
1160,
1161,
1162,https://www.ema.europa.eu/en/documents/product-information/ultibro-breezhaler-epar-product-information_en.pdf
1163,https://www.ema.europa.eu/en/documents/product-information/bortezomib-fresenius-kabi-epar-product-information_en.pdf 
1164,https://www.ema.europa.eu/en/documents/product-information/eurartesim-epar-product-information_en.pdf
1165,https://www.ema.europa.eu/en/documents/product-information/neuraceq-epar-product-information_en.pdf
1166,https://www.ema.europa.eu/en/documents/product-information/idefirix-epar-product-information_en.pdf
1167,https://www.ema.europa.eu/en/documents/product-information/adakveo-epar-product-information_en.pdf
1168,https://www.ema.europa.eu/en/documents/assessment-report/bropair-spiromax-epar-public-assessment-report_en.pdf
1169,https://www.ema.europa.eu/en/documents/product-information/seffalair-spiromax-epar-product-information_en.pdf
1170,https://www.ema.europa.eu/en/documents/product-information/xerava-epar-product-information_en.pdf
1171,https://www.ema.europa.eu/documents/product-information/adtralza-epar-product-information_en.pdf
1172,https://www.ema.europa.eu/documents/product-information/pelgraz-epar-product-information_en.pdf
1173,https://www.ema.europa.eu/en/documents/product-information/tarceva-epar-product-information_en.pdf
1174,https://www.ema.europa.eu/en/documents/product-information/inovelon-epar-product-information_en.pdf
1175,https://www.ema.europa.eu/en/documents/product-information/sutent-epar-product-information_en.pdf
1176,https://www.ema.europa.eu/en/documents/product-information/cholib-epar-product-information_en.pdf
1177,https://www.ema.europa.eu/en/documents/product-information/eviplera-epar-product-information_en.pdf
1178,https://www.ema.europa.eu/en/documents/product-information/thiotepa-riemser-epar-product-information_en.pdf
1179,https://www.ema.europa.eu/en/documents/product-information/ifirmasta-epar-product-information_en.pdf
1180,https://www.ema.europa.eu/en/documents/product-information/verquvo-epar-product-information_en.pdf
1181,
1182,https://www.ema.europa.eu/en/documents/product-information/vizimpro-epar-product-information_en.pdf
1183,https://www.ema.europa.eu/en/documents/product-information/stayveer-epar-product-information_en.pdf
1184,https://www.ema.europa.eu/en/documents/product-information/competact-epar-product-information_en.pdf
1185,https://www.ema.europa.eu/en/documents/product-information/dacogen-epar-product-information_en.pdf
1186,https://www.ema.europa.eu/en/documents/product-information/ecalta-epar-product-information_en.pdf
1187,https://www.ema.europa.eu/documents/product-information/striascan-epar-product-information_en.pdf
1188,https://www.ema.europa.eu/en/documents/product-information/temodal-epar-product-information_en.pdf
1189,https://www.ema.europa.eu/en/documents/product-information/levemir-epar-product-information_en.pdf
1190,https://www.ema.europa.eu/en/documents/product-information/zometa-epar-product-information_en.pdf
1191,https://www.ema.europa.eu/en/documents/product-information/xenleta-epar-product-information_en.pdf
1192,https://www.ema.europa.eu/en/documents/product-information/daurismo-epar-product-information_en.pdf
1193,https://www.ema.europa.eu/en/documents/product-information/strensiq-epar-product-information_en.pdf
1194,https://www.ema.europa.eu/en/documents/product-information/praxbind-epar-product-information_en.pdf
1195,https://www.ema.europa.eu/en/documents/product-information/introna-epar-product-information_en.pdf
1196,https://www.ema.europa.eu/en/documents/product-information/baqsimi-epar-product-information_en.pdf
1197,https://www.ema.europa.eu/en/documents/product-information/trulicity-epar-product-information_en.pdf
1198,https://www.ema.europa.eu/en/documents/product-information/celsunax-epar-product-information_en.pdf
1199,https://www.ema.europa.eu/en/documents/product-information/lyumjev-previously-liumjev-epar-product-information_en.pdf
1200,https://www.ema.europa.eu/en/documents/product-information/bretaris-genuair-epar-product-information_en.pdf
1201,https://www.ema.europa.eu/en/documents/product-information/zevalin-epar-product-information_en.pdf
1202,https://www.ema.europa.eu/en/documents/product-information/orphacol-epar-product-information_en.pdf
1203,https://www.ema.europa.eu/en/documents/product-information/eklira-genuair-epar-product-information_en.pdf
1204,https://www.ema.europa.eu/en/documents/product-information/duaklir-genuair-epar-product-information_en.pdf
1205,https://www.ema.europa.eu/documents/product-information/giapreza-epar-product-information_en.pdf
1206,https://www.ema.europa.eu/en/documents/product-information/brimica-genuair-epar-product-information_en.pdf
1207,https://www.ema.europa.eu/en/documents/product-information/doptelet-epar-product-information_en.pdf
1208,
1209,https://www.ema.europa.eu/en/documents/product-information/vimizim-epar-product-information_en.pdf
1210,https://www.ema.europa.eu/en/documents/product-information/diacomit-epar-product-information_en.pdf
1211,
1212,https://www.ema.europa.eu/en/documents/product-information/biresp-spiromax-epar-product-information_en.pdf
1213,https://www.ema.europa.eu/en/documents/product-information/carbaglu-epar-product-information_en.pdf
1214,https://www.ema.europa.eu/en/documents/product-information/ketoconazole-hra-epar-product-information_en.pdf
1215,https://www.ema.europa.eu/en/documents/product-information/velcade-epar-product-information_en.pdf
1216,https://www.ema.europa.eu/en/documents/product-information/nityr-epar-product-information_en.pdf
1217,https://www.ema.europa.eu/en/documents/product-information/cayston-epar-product-information_en.pdf
1218,https://www.ema.europa.eu/en/documents/product-information/truvada-epar-product-information_en.pdf
1219,https://www.ema.europa.eu/en/documents/product-information/xeplion-epar-product-information_en.pdf
1220,https://www.ema.europa.eu/en/documents/product-information/pioglitazone-actavis-epar-product-information_en.pdf
1221,https://www.ema.europa.eu/en/documents/product-information/cholestagel-epar-product-information_en.pdf
1222,https://www.ema.europa.eu/en/documents/product-information/novoeight-epar-product-information_en.pdf
1223,https://www.ema.europa.eu/en/documents/product-information/busulfan-fresenius-kabi-epar-product-information_en.pdf
1224,https://www.ema.europa.eu/en/documents/product-information/axura-epar-product-information_en.pdf
1225,https://www.ema.europa.eu/en/documents/product-information/sylvant-epar-product-information_en.pdf
1226,
1227,https://www.ema.europa.eu/en/documents/product-information/hepsera-epar-product-information_en.pdf
1228,https://www.ema.europa.eu/en/documents/product-information/abiraterone-accord-epar-product-information_en.pdf
1229,https://www.ema.europa.eu/en/documents/product-information/victoza-epar-product-information_en.pdf
1230,https://www.ema.europa.eu/en/documents/product-information/odomzo-epar-product-information_en.pdf
1231,https://www.ema.europa.eu/en/documents/product-information/ecansya-epar-product-information_en.pdf
1232,https://www.ema.europa.eu/en/documents/product-information/giotrif-epar-product-information_en.pdf
1233,https://www.ema.europa.eu/en/documents/product-information/vantobra-previously-tobramycin-pari-epar-product-information_en.pdf
1234,https://www.ema.europa.eu/en/documents/product-information/ixiaro-epar-product-information_en.pdf
1235,https://www.ema.europa.eu/en/documents/product-information/coagadex-epar-product-information_en.pdf
1236,https://www.ema.europa.eu/en/documents/product-information/amyvid-epar-product-information_en.pdf
1237,https://www.ema.europa.eu/en/documents/product-information/amglidia-epar-product-information_en.pdf
1238,https://www.ema.europa.eu/en/documents/product-information/slenyto-epar-product-information_en.pdf
1239,https://www.ema.europa.eu/en/documents/product-information/bondronat-epar-product-information_en.pdf
1240,https://www.ema.europa.eu/en/documents/product-information/neurobloc-epar-product-information_en.pdf
1241,https://www.ema.europa.eu/en/documents/product-information/conbriza-epar-product-information_en.pdf
1242,https://www.ema.europa.eu/en/documents/product-information/plegridy-epar-product-information_en.pdf
1243,https://www.ema.europa.eu/en/documents/product-information/pravafenix-epar-product-information_en.pdf
1244,https://www.ema.europa.eu/en/documents/product-information/ruconest-epar-product-information_en.pdf
1245,https://www.ema.europa.eu/en/documents/product-information/orfadin-epar-product-information_en.pdf
1246,https://www.ema.europa.eu/en/documents/product-information/elocta-epar-product-information_en.pdf
1247,
1248,https://www.ema.europa.eu/en/documents/product-information/edarbi-epar-product-information_en.pdf
1249,https://www.ema.europa.eu/en/documents/product-information/esmya-epar-product-information_en.pdf
1250,https://www.ema.europa.eu/en/documents/product-information/neofordex-epar-product-information_en.pdf
1251,https://www.ema.europa.eu/en/documents/product-information/circadin-epar-product-information_en.pdf
1252,https://www.ema.europa.eu/en/documents/product-information/yttriga-epar-product-information_en.pdf
1253,https://www.ema.europa.eu/en/documents/product-information/defitelio-epar-product-information_en.pdf
1254,https://www.ema.europa.eu/en/documents/product-information/jetrea-epar-product-information_en.pdf
1255,https://www.ema.europa.eu/en/documents/product-information/inomax-epar-product-information_en.pdf
1256,https://www.ema.europa.eu/en/documents/product-information/livogiva-epar-product-information_en.pdf
1257,https://www.ema.europa.eu/en/documents/product-information/rebif-epar-product-information_en.pdf
1258,https://www.ema.europa.eu/en/documents/product-information/telmisartan-actavis-epar-product-information_en.pdf
1259,https://www.ema.europa.eu/en/documents/product-information/kinzalmono-epar-product-information_en.pdf
1260,https://www.ema.europa.eu/en/documents/product-information/isturisa-epar-product-information_en.pdf
1261,https://www.ema.europa.eu/en/documents/product-information/pramipexole-accord-epar-product-information_en.pdf
1262,https://www.ema.europa.eu/en/documents/product-information/pritor-epar-product-information_en.pdf
1263,https://www.ema.europa.eu/en/documents/product-information/atriance-epar-product-information_en.pdf
1264,https://www.ema.europa.eu/en/documents/product-information/silapo-epar-product-information_en.pdf
1265,https://www.ema.europa.eu/en/documents/product-information/insulatard-epar-product-information_en.pdf
1266,https://www.ema.europa.eu/en/documents/product-information/novorapid-epar-product-information_en.pdf
1267,
1268,https://www.ema.europa.eu/en/documents/product-information/evicel-epar-product-information_en.pdf
1269,https://www.ema.europa.eu/en/documents/product-information/memantine-lek-epar-product-information_en.pdf
1270,https://www.ema.europa.eu/en/documents/product-information/novomix-epar-product-information_en.pdf
1271,https://www.ema.europa.eu/en/documents/product-information/ammonaps-epar-product-information_en.pdf
1272,https://www.ema.europa.eu/en/documents/product-information/docetaxel-kabi-epar-product-information_en.pdf
1273,https://www.ema.europa.eu/en/documents/product-information/lymphoseek-epar-product-information_en.pdf
1274,https://www.ema.europa.eu/en/documents/product-information/protaphane-epar-product-information_en.pdf
1275,https://www.ema.europa.eu/en/documents/product-information/tasmar-epar-product-information_en.pdf
1276,https://www.ema.europa.eu/en/documents/product-information/hemangiol-epar-product-information_en.pdf
1277,https://www.ema.europa.eu/en/documents/product-information/actrapid-epar-product-information_en.pdf
1278,https://www.ema.europa.eu/en/documents/product-information/fulvestrant-mylan-epar-product-information_en.pdf
1279,https://www.ema.europa.eu/en/documents/product-information/actraphane-epar-product-information_en.pdf
1280,https://www.ema.europa.eu/en/documents/product-information/xultophy-epar-product-information_en.pdf
1281,https://www.ema.europa.eu/en/documents/product-information/mixtard-epar-product-information_en.pdf
1282,https://www.ema.europa.eu/en/documents/product-information/spectrila-epar-product-information_en.pdf
1283,https://www.ema.europa.eu/en/documents/product-information/lumark-epar-product-information_en.pdf
1284,https://www.ema.europa.eu/en/documents/product-information/visudyne-epar-product-information_en.pdf
1285,https://www.ema.europa.eu/documents/product-information/trecondi-epar-product-information_en.pdf
1286,https://www.ema.europa.eu/en/documents/product-information/omidria-epar-product-information_en.pdf
1287,https://www.ema.europa.eu/en/documents/product-information/olanzapine-glenmark-epar-product-information_en.pdf
1288,https://www.ema.europa.eu/en/documents/product-information/olazax-epar-product-information_en.pdf
1289,https://www.ema.europa.eu/en/documents/product-information/namuscla-epar-product-information_en.pdf
1290,https://www.ema.europa.eu/en/documents/product-information/olanzapine-glenmark-europe-epar-product-information_en.pdf
1291,https://www.ema.europa.eu/en/documents/product-information/mepact-epar-product-information_en.pdf
1292,https://www.ema.europa.eu/en/documents/product-information/olazax-disperzi-epar-product-information_en.pdf
1293,https://www.ema.europa.eu/en/documents/product-information/sancuso-epar-product-information_en.pdf
1294,https://www.ema.europa.eu/en/documents/product-information/ivabradine-anpharm-epar-product-information_en.pdf
1295,https://www.ema.europa.eu/en/documents/product-information/invega-epar-product-information_en.pdf
1296,https://www.ema.europa.eu/en/documents/product-information/xenical-epar-product-information_en.pdf
1297,
1298,https://www.ema.europa.eu/en/documents/product-information/kuvan-epar-product-information_en.pdf
1299,https://www.ema.europa.eu/en/documents/product-information/ulunar-breezhaler-epar-product-information_en.pdf
1300,https://www.ema.europa.eu/en/documents/product-information/pylobactell-epar-product-information_en.pdf
1301,https://www.ema.europa.eu/en/documents/product-information/cetrotide-epar-product-information_en.pdf
1302,
1303,https://www.ema.europa.eu/en/documents/product-information/binocrit-epar-product-information_en.pdf
1304,https://www.ema.europa.eu/en/documents/product-information/epoetin-alfa-hexal-epar-product-information_en.pdf
1305,https://www.ema.europa.eu/en/documents/product-information/savene-epar-product-information_en.pdf
1306,https://www.ema.europa.eu/en/documents/product-information/ovaleap-epar-product-information_en.pdf
1307,https://www.ema.europa.eu/en/documents/product-information/vedrop-epar-product-information_en.pdf
1308,https://www.ema.europa.eu/en/documents/product-information/wilzin-epar-product-information_en.pdf
1309,https://www.ema.europa.eu/en/documents/product-information/cyanokit-epar-product-information_en.pdf
1310,https://www.ema.europa.eu/en/documents/product-information/ceplene-epar-product-information_en.pdf
1311,https://www.ema.europa.eu/en/documents/product-information/clopidogrel-hcs-epar-product-information_en.pdf
1312,https://www.ema.europa.eu/en/documents/product-information/aloxi-epar-product-information_en.pdf
1313,https://www.ema.europa.eu/en/documents/product-information/prandin-epar-product-information_en.pdf
1314,https://www.ema.europa.eu/en/documents/product-information/kogenate-bayer-epar-product-information_en.pdf
1315,https://www.ema.europa.eu/en/documents/product-information/litak-epar-product-information_en.pdf
1316,https://www.ema.europa.eu/en/documents/product-information/novonorm-epar-product-information_en.pdf
1317,https://www.ema.europa.eu/en/documents/product-information/scintimun-epar-product-information_en.pdf
1318,https://www.ema.europa.eu/en/documents/product-information/foscan-epar-product-information_en.pdf
1319,https://www.ema.europa.eu/en/documents/product-information/quadramet-epar-product-information_en.pdf
